Page last updated: 2024-08-23

radium and Bone Neoplasms

radium has been researched along with Bone Neoplasms in 483 studies

Research

Studies (483)

Timeframe	Studies, this research(%)	All Research%
pre-1990	113 (23.40)	18.7374
1990's	25 (5.18)	18.2507
2000's	23 (4.76)	29.6817
2010's	240 (49.69)	24.3611
2020's	82 (16.98)	2.80

Authors

Authors	Studies
Agarwal, N; Bruno, A; George, D; Guo, H; Higano, CS; Jiao, X; Miller, K; Saad, F; Sandström, P; Sartor, O; Shore, N; Sternberg, CN; Tombal, B; Verholen, F	1
Horio, T; Hosono, M; Kakehi, Y; Kinuya, S; Masumori, N; Okayama, Y; Sunaya, T; Takahashi, S; Uemura, H	2
Akakura, K; Ledesma, DA; Miyazaki, K; Seo, C; Stroupe, A; Uemura, H; Uzumcu, A	1
Alencar, LMR; Gemini-Piperni, S; Lima, RC; Santos-Oliveira, R; Yang, Y	1
Anderson, P; Kairemo, K; Macapinlac, HA; Rao, A; Ravizzini, G; Roszik, J; Subbiah, V	1
Abend, M; Barsegian, V; Eberlein, U; Hoffmann, MA; Lassmann, M; Majewski, M; Miederer, M; Nestler, T; Ostheim, P; Port, M; Rump, A; Schreckenberger, M	1
Saganich, C; Zgaljardic, M	1
Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kano, H; Makino, T; Mizokami, A; Naito, R; Shimada, T; Yaegashi, H	1
Huang, LH; Ou, YC; Tseng, NC; Weng, WC	1
Agarwal, N; Constantinovici, N; George, DJ; Guo, H; Higano, CS; Jiao, X; Miller, K; Reeves, J; Saad, F; Sandström, P; Sartor, O; Shore, N; Sternberg, CN; Tombal, B; Verholen, F	1
Alencar, LMR; Batista, BDS; França, ARS; Gemini-Piperni, S; Lima, RC; Pijeira, MSO; Rates, ERD; Santos-Oliveira, R; Yang, Y	1
Bambury, RM; Jamaluddin, MF; Kelly, P; Lyons, C; McCarthy, L; Peters, N; Power, DG	1
El Khouli, R; Kunos, CA; Lemieux, B; Liu, X; Myint, ZW; St Clair, WH; Yan, D	1
Bloom, JR; Castillejos, AG; Jones, B; Patel, N; Rosenstein, BS; Stock, RG	1
Bryce, AH; Choo, R; Ho, TH; Jaeger, E; Kendi, AT; Keole, SR; Kosiorek, HE; Ledet, E; Liu, AJ; Moore, CN; Quevedo, F; Sartor, O; Singh, P; Tzou, K; Ueberroth, BE; Wong, WW	1
Custers, JAE; Gerritsen, WR; Janssen, MJR; Mehra, N; Oving, IM; Oyen, WJG; Prins, JB; Terheggen, F; van Basten, JP; van de Luijtgaarden, ACM; van den Berkmortel, F; van der Doelen, MJ; van Oort, IM; van Schelven, WD; Wyndaele, DNJ	1
Hasumi, H; Kawahara, T; Makiyama, K; Miyoshi, Y; Ninomiya, S; Sato, M; Takeshima, T; Uemura, H	1
Alonso-Gordoa, T; Bonfill, T; Borrega, P; Carles, J; Collado, R; Gallardo, E; Garcías de España, C; Garde, J; González-Del-Alba, A; Malfettone, A; Mellado, B; Méndez-Vidal, MJ; Morales-Barrera, R; Paredes, P; Piulats, JM; Reig, O; Sampayo-Cordero, M; Suárez, C; Vázquez, S	1
Braz, D; da Silva, AX; de Sá, LV; Lima, LFC; Segars, WP; Silva, CCO	1
Doehn, C; Eichenauer, R; Grund, C; Hellmis, E; Hempel, E; Johannsen, M; Jores, C; Klier, J; König, F; Schönfelder, R; Schröder, J; Zillmann, R	1
Eriksson, MH; Garcia-Albeniz, X; Kjellman, A; Lissbrant, IF; Martinez, D; Sandstrom, P; Stattin, P; Ullén, A; Vassilev, Z; Weinrib, R; Westerberg, M	1
Kamoto, T; Kimura, T; Mukai, S; Nagano, M; Okabe, KO; Onizuka, C; Otuka, I; Shirakawa, T; Takamori, H; Terada, N; Ueno, T; Yamashita, Y	1
Blas, L; Eto, M; Hori, Y; Kiyoshima, K; Kuroiwa, K; Matsumoto, T; Morokuma, F; Nakamura, M; Seki, N; Shiota, M; Yokomizo, A	2
Daimon, T; Hosono, M; Igeta, M; Ishiwata, Y; Ito, K; Kawahara, T; Kitajima, K; Kono, Y; Kuyama, J; Miyake, H; Narita, M; Otani, T; Seko-Nitta, A; Suga, T; Sugawara, S; Tamaki, Y; Toriihara, A; Watanabe, S; Yamakado, K; Yamamoto, S	1
Danilenko, VV; Shypko, AF; Solodyannikova, OI; Sukach, GG	1
Attwood, K; George, S; Kothari, S; Lamonica, D; Levine, E; Shariftabrizi, A	1
K Das, M; Mandal, S; Nayak, P; Ram, P	1
Alencar, LMR; da Silva Batista, B; Gemini-Piperni, S; İlem-Özdemir, D; Ricci-Junior, E; Rossi, AM; Santos-Oliveira, R	1
Alhoniemi, E; Haendler, B; Käkönen, SM; Knuuttila, M; Mumberg, D; Schatz, CA; Schlicker, A; Scholz, A; Sjöholm, B; Suominen, MI; Vääräniemi, J	1
Briones, J; Emmenegger, U; Hardisty, MR; Khan, M; Lyons, F; Naimi, MF; Parshad, S; Phillips, CM; Sidhu, AK; Smoragiewicz, M; Whyne, CM	1
Abramowitz, E; O'Sullivan, JM; Sierra-Scacalossi, L	1
Chang, LW; Chen, CC; Chen, CS; Cheng, CL; Chiu, KY; Hung, SC; Li, JR; Lin, CY; Lu, K; Ou, YC; Wang, SC; Wang, SS; Yang, CK; Yang, HC	1
Yuasa, T	1
Alonzi, R; Blackledge, MD; Chatfield, P; Chua, S; Cook, GJR; Curcean, A; Du, Y; Finch, J; Hafeez, S; Hall, E; Koh, DM; Murray, I; Padhani, AR; Parker, C; Perry, S; Staffurth, J; Stidwill, H; Tovey, H; Tree, A; Tunariu, N	1
Sartor, O	3
Käkönen, SM; Scholz, A; Suominen, MI; Wilson, T	1
Frank, SJ; Heinrich, D; Keizman, D; Li, R; Mariados, N; Méndez Vidal, MJ; Nordquist, LT; Peer, A; Procopio, G; Pulkkanen, K; Rosenbaum, E; Sartor, O; Severi, S; Thellenberg Karlsson, C; Trandafir, L; Trigo, J; Wagner, V	1
Dizdarevic, S; McCready, R; Vinjamuri, S	1
Fujii, Y; Hinotsu, S; Izumi, K; Kimura, G; Mizokami, A	1
Leung, E	1
Fricke, E; Goebell, PJ; Johannsen, M; Klier, J; König, F; Mehl, S; Mommsen, C; Pfister, D; Sahlmann, CO; Strauß, A; Werner, A	1
Borsellino, N; Costa, R; Gebbia, V; Licari, M; Murabito, A; Princiotta, A; Sanfilippo, C; Scalici Gesolfo, C; Serretta, V; Tripoli, V; Valerio, MR; Verderame, F	1
Corey, E; Guise, TA; Gulley, JL; Kevin Kelly, W; Morris, MJ; Quinn, DI; Scholz, A; Sgouros, G	1
Hosono, M; Kakehi, Y; Kikukawa, H; Kimura, G; Kinuya, S; Krissel, H; Matsubara, N; Mizokami, A; Nagamori, S; Nakamura, M; Siegel, J; Uemura, H	1
Chasen, BA; Damodaran, S; Fujii, T; Gao, H; Hortobagyi, GN; Ibrahim, NK; Iwase, T; Lim, B; Liu, DD; Lucci, A; Reuben, JM; Saigal, B; Shen, Y; Tahara, RK; Tripathy, D; Ueno, NT	1
Aloise, I; Colosi, M; Farcomeni, A; Frantellizzi, V; Ippoliti, MD; Pani, A; Pani, R; Polito, C; Vincentis, G	1
Badrising, SK; Beeker, A; Bergman, AM; Celik, F; Coenen, JLLM; Haanen, JB; Hamberg, P; Lam, MGEH; Loosveld, OJL; Louhanepessy, RD; Oostdijk, A; van der Noort, V; Vegt, E; Wagenaar, N; Zuetenhorst, H; Zwart, W	1
Agarwal, N; Batten, J; Boucher, K; Gupta, S; Haaland, B; Hahn, AW; Hawks, J; Hoffman, JM; Maughan, BL; Morton, K; Nachaegari, G; Nussenzveig, R; Santos, VS; Thorley, J; Wang, X	1
Anand, A; Brown, J; Brown, S; Coleman, R; Flanagan, L; Howell, S; Kendall, J; MacPherson, I; Palmieri, C; Rathbone, E; Reid, A; Twelves, C	1
Davis, ID; Epstein, RJ; Graff, JN; Gurney, H; Hussain, M; Leung, E; Peer, A; Rosenbaum, E; Saad, F; Sternberg, CN; Trandafir, L; Vaishampayan, UN; Wagner, VJ; Wu, B	1
Casadei, C; Cursano, MC; De Giorgi, U; Iuliani, M; Paganelli, G; Santini, D; Stellato, M; Tonini, G	1
Albano, D; Bertagna, F; Cerudelli, E; Cossalter, E; Durmo, R; Gazzilli, M; Giubbini, R; Panarotto, MB	1
Bagni, O; Basile, P; Filippi, L; Schillaci, O	1
Brito, AE; Etchebehere, E	1
Abou, DS; Finley, PA; Jha, AK; Riddle, RC; Rittenbach, A; Simons, BW; Thorek, DLJ; Tomlinson, RE; Tsui, B; Ulmert, D	1
Chiti, A; Gelardi, F; Mazziotti, G; Pepe, G; Rodari, M; Tosi, G; Zucali, PA	1
Agostini, S; Alongi, P; Baldari, S; Biasco, E; Borsatti, E; Bortolus, R; Caffo, O; Cortesi, E; De Vincentis, G; Facchini, G; Fanti, S; Filice, A; Frantellizzi, V; Galli, L; Masini, C; Monari, F; Pignata, S; Rossetti, S; Spada, M; Tucci, M; Zichi, C	1
Dionisi, V; Fanti, S; Ghedini, P; Monari, F; Morganti, AG; Rizzini, EL	1
Andreola, M; Cindolo, L; Cosma, L; Costa, R; De Vincentis, G; Dionisi, V; Farcomeni, A; Frantellizzi, V; Lavelli, V; Lodi Rizzini, E; Mascia, M; Monari, F; Murabito, A; Nappi, AG; Nuvoli, S; Rubini, G; Spanu, A	1
Dorff, TB; Kortylewski, M; Posadas, E; Quinn, D; Stein, C; Synold, T	1
Bruland, ØS; Juzeniene, A; Larsen, RH; Stenberg, VY	1
George, DJ; Higano, CS; Jiao, X; Kalinovsky, J; Miller, K; Saad, F; Sartor, O; Shore, N; Sternberg, CN; Tangirala, K; Tombal, B	1
Aben, KK; Bergman, AM; Celik, F; Coenen, JL; den Bosch, JV; der Meer, SV; Gerritsen, WR; Hendriks, MP; Kuppen, MC; Lavalaye, J; Polee, MB; Somford, DM; Uyl-de Groot, CA; van den Bergh, AC; van den Eertwegh, AJ; van der Doelen, MJ; van Oort, IM; Westgeest, HM	1
Antonarakis, ES; Caldwell, T; Carducci, MA; Deek, MP; Denmeade, S; Deville, C; DeWeese, TL; Dipasquale, S; Dudley, S; Eisenberger, MA; Gorin, MA; Greco, SC; Hasan, H; Hobbs, RF; Huang, J; Kiess, AP; Leitzel, J; Malek, R; Markowski, M; Paller, CJ; Phillips, R; Pienta, KJ; Pomper, MG; Powell, J; Radwan, N; Rowe, SP; Song, DY; Thompson, E; Tran, PT; Wang, H; Wendler, D	1
Banks, KP; Brown, RKJ; Buscombe, JR; Hurwitz, M; Jacene, HA; Klitzke, AK; Lamonica, D; Lu, Y; Pryma, DA; Rohren, EM; Speer, TW; Subramaniam, RM; Thompson, HM; Tomblyn, MB; Wong, WW; Xiao, Y	1
Casarin, S; Dondossola, E	1
Etchebehere, E; Lima, M; Minekawa, T; Moraes, A; Santos, A	1
Hashimoto, K; Naito, M; Ukai, R	1
Cindolo, L; Costa, RP; DE Vincentis, G; Dionisi, V; Farcomeni, A; Ferrari, C; Frantellizzi, V; Lavelli, V; Lodi Rizzini, E; Mascia, M; Monari, F; Nuvoli, S; Pontico, M; Rubini, G; Spanu, A; Tripoli, V	1
Dandapani, SV; Twardowski, P; Wong, J	1
Appukkuttan, S; Bhak, RH; Cheng, M; Duh, MS; Korves, C; McKay, RR; Silver, R; Simmons, SJ; Taplin, ME	1
Kakimoto, KI; Kanaki, T; Nagahara, A; Nakai, Y; Nakayama, M; Nishimura, K; Okuda, Y; Tanaka, R; Yamamoto, Y	1
Ahmadzadehfar, H; Conrad, R; Essler, M; Herrmann, K; Hirmas, N; Marinova, M; Sraieb, M	1
Fukuta, F; Hashimoto, K; Hinotsu, S; Hori, M; Hotta, H; Kato, R; Kitamura, H; Kobayashi, K; Kunishima, Y; Maehana, T; Masumori, N; Miyamoto, S; Miyoshi, Y; Nishiyama, N; Okada, M; Sakata, KI; Shindo, T; Takahashi, A; Tanaka, T; Tsuboi, Y; Uemura, H; Yanase, M	1
De Vincentis, G; Frantellizzi, V; Lazri, J; Pani, A; Pontico, M	1
Chen, CH; Ding, Q; Guo, H; Guo, J; Jiang, Y; Krissel, H; Lee, JL; Li, F; Li, H; Li, R; Liu, X; Ma, J; Ng, QS; Park, SH; Shi, H; Sun, Y; Tian, Y; Wagner, VJ; Wang, S; Yao, X; Yuan, J; Zhang, X; Zheng, R; Zhou, D; Zhou, F; Zhou, T; Zou, Q	1
De Vincentis, G; Frantellizzi, V	1
Alongi, F; Alongi, P; Baldari, S; Biasco, E; Borsatti, E; Bortolus, R; Caffo, O; Cortesi, E; Costa, RP; Facchini, G; Fanti, S; Filice, A; Frantellizzi, V; Monari, F; Murabito, A; Palermo, A; Pignata, S; Pinto, C; Salgarello, M; Sbrana, A; Spada, M; Tucci, M; Vincentis, G; Zichi, C	1
Gerritsen, WR; Ma, Y; Mehra, N; Nilsson, S; Stockhaus, A; Ullén, A; van der Doelen, MJ; van Oort, IM; Yachnin, J	1
Amling, CL; Aronson, WJ; Cooperberg, MR; De Hoedt, AM; Freedland, SJ; Howard, LE; Kane, CJ; Klaassen, Z; Polascik, TJ; Terris, MK; Vidal, AC; Zhao, H	1
Corn, P; Efstathiou, E; Gallick, GE; Gentile, E; Guerra, L; Hoang, A; Lee, YC; Lin, SC; Lin, SH; Logothetis, CJ; Madan, N; Melancon, MP; Navone, N; Panaretakis, T; Parikh, N; Santos, E; Song, JH; Subudhi, SK; Troncoso, P; Vardaki, I; Yu, G	1
Abrantes, AM; Botelho, MF; Caramelo, FJ; Costa, G; Figueiredo, A; Gonçalves, AC; Marques, IA; Matafome, P; Neves, AR; Pereira, CC; Pires, AS; Rodrigues, T; Seiça, R; Tavares-da-Silva, E; Teixeira, JP	1
Alongi, F; Alongi, P; Baldari, S; Borsatti, E; Bortolus, R; Caffo, O; Cortesi, E; Costa, RP; De Giorgi, U; De Vincentis, G; Donner, D; Facchini, G; Fanti, S; Frantellizzi, V; Galli, L; Lo Re, G; Masini, C; Monari, F; Morabito, A; Pignata, S; Pinto, C; Salgarello, M; Sbrana, A; Spada, M; Tucci, M; Zichi, C	1
Alonzi, R; Blackledge, M; Chatfield, P; Curcean, S; Finch, J; Hall, E; Hijab, A; Mu Koh, D; Padhani, A; Parker, C; Perry, S; Staffurth, J; Stidwill, H; Tovey, H; Tree, A; Tunariu, N	1
Appukkuttan, S; Sartor, O; Tsao, CK; Weiss, J	1
Basch, EM; Brower, B; Crona, DJ; Dunn, MW; Godley, PA; Khandani, AH; Kim, SI; Milowsky, MI; Morgan, KP; Rose, TL; Szeto, AH; Whang, YE	1
Falvello, V; Van Poznak, C	1
Strane, T	1
Amthauer, H; Genseke, P; Großer, OS; Kupitz, D; Ricke, J; Ruf, J; Wallbaum, T; Wissel, H	1
Baldari, S; Boni, G; Bortolus, R; Caffo, O; Conti, G; De Vincentis, G; Monari, F; Procopio, G; Santini, D; Seregni, E; Valdagni, R	1
Adamo, V; Baldari, S; Caffo, O; Franchina, T; Picciotto, M; Provazza, G; Ricciardi, GRR; Russo, A; Sava, S	1
Doi, T; Hosono, M; Kinuya, S; Matsubara, N; Uemura, H; Yajima, Y	1
Albert, NL; Bartenstein, P; Fendler, WP; Gratzke, C; Herlemann, A; Ilhan, H; la Fougère, C; Rominger, A; Stief, CG; Tirichter, N; Wenter, V	1
García Cañamaque, L; García De la Peña, P; Rioja Parada, C	1
Izumi, K; Kadono, Y; Kitagawa, Y; Konaka, H; Mizokami, A	1
Saad, F; Traboulsi, SL	1
Vogelzang, NJ	2
Flux, GD	1
Cozar-Olmos, JM; Figueiredo-de Castro, A; Juárez-Soto, A; Miñana-López, B; Rodríguez-Antolín, A; Silva-Marins, C; Sousa-Campo, R; Unda-Urzaiz, M	1
Fukasawa, S; Hosono, M; Kawasaki, Y; Kikukawa, H; Kimura, G; Kinuya, S; Kosaka, T; Masumori, N; Matsubara, N; Mizokami, A; Nagamori, S; Nasu, Y; Sugiyama, T; Tsutsui, H; Uemura, H; Wakumoto, Y; Yamaguchi, I; Yokomizo, A; Yonese, J	1
Aupee, O; Bertolaso, P; Cazeau, AL; Gross-Goupil, M; Le Moulec, S; Leroy, L; Ravaud, A; Roubaud, G	1
Alvarez Cabellos, R; García Vicente, AM; Mohedano Mohedano, N; Sanchez Gil, B; Soriano Castrejón, Á	1
Fosbøl, MØ; Kjaer, A; Mortensen, J; Petersen, PM	1
Beuzeboc, P; Cachin, F; Deshayes, E; Hennequin, C; Houédé, N; Huglo, D; Kassab-Chahmi, D; Rebillard, X; Roumiguie, M; Rozet, F; Thibault, C	1
George, DJ	1
Frank, SJ; Heinrich, D; Keizman, D; Li, R; Mariados, N; Méndez Vidal, MJ; Nordquist, LT; Peer, A; Procopio, G; Pulkkanen, K; Rosenbaum, E; Sartor, O; Severi, S; Thellenberg Karlsson, C; Trigo Perez, JM; Wagner, V	1
Grimm, MO; von Rundstedt, FC; Winter, BM	1
Cha, TL; Chang, WY; Huang, CY; Huang, SP; Lin, CC; Ou, YC; Pang, ST; Shen, DH; Vogelzang, NJ; Wu, TT; Wu, WJ	1
Carles, J; Climent, MÁ; Olmos, D; Pinto, Á; Rodriguez-Vida, A; Torregrosa, MD	1
de Clermont, H; Laffon, E; Marthan, R; Paycha, F	1
Kang, I; Kang, Y; Kim, JW; Petrylak, DP; Shin, MS	1
Gerritsen, WR; Janssen, MJR; Jonker, MA; Kuppen, MCP; Mehra, N; van der Doelen, MJ; van Oort, IM	1
Ichimura, A; Jinzaki, M; Nakahara, T; Nakajima, K; Owaki, Y	1
Poon, DMC; Wong, KCW	1
Chittenden, SJ; Flux, GD; Hindorf, C; Parker, CC; Pratt, BE	1
Arranz, JA; Carles, J; Castellano, D; Del Alba, AG; Donas, JG; Esteban, E; Germà, JR; Hernando, S; Laínez, N; León, L; López-Brea, M; López-Criado, P; Maroto, P; Mellado, B; Méndez, MJ; Moretones, C; Pérez-Gracia, JL; Pérez-Valderrama, B; Pinto, Á; Reynés, G; Sáez, MI	1
Andreeff, M; Becherer, A; Bockisch, A; Bodei, L; Delgado-Bolton, RC; Fricke, E; Gabriel, M; Geworski, L; Handkiewicz-Junak, D; Heinzel, A; Krause, BJ; Krause, T; Mitterhauser, M; Poeppel, TD; Sonnenschein, W	1
Cicero, G; Costa, RP; De Luca, R; Murabito, A; Tripoli, V	1
Fukai, S; Koizumi, M; Miyaji, N; Motegi, K; Nakazawa, S; Takiguchi, T; Umeda, T	1
Barsanti, R; Zustovich, F	1
De Vincentis, G; Farcomeni, A; Follacchio, GA; Frantellizzi, V; Pacilio, M; Pani, R; Pellegrini, R	1
Mostaghel, EA; Pritchard, CC; Ramos, JD; Yu, EY	1
Heidenreich, A; Nilsson, S; Parker, C; Shore, N	1
Delgado Bolton, RC; Giammarile, F	1
Coleman, RE; Den, R; Logothetis, C; Morris, MJ	1
Amorim, BJ; Bernardo, WM; Brito, AE; Etchebehere, E; Martello, M	1
Dainiak, N; Goans, RE; Iddins, CJ; McComish, SL; Tolmachev, SY; Toohey, RE	1
Wei, ZF; Xu, XF; Zhang, ZY	1
Gomella, L; Jacene, H; Rohren, EM; Yu, EY	1
Fukada, J; Ichimura, A; Jinzaki, M; Kosaka, T; Nakahara, T; Owaki, Y	1
Gillessen, S; Isensee, G; Müller, J; Omlin, A; Péporté, A; Schmid, S	1
Mulders, PFA; Niepel, D; Saad, F; Sternberg, CN; Tombal, BF	1
Bauriaud-Mallet, M; Ben Bouallègue, F; Brillouet, S; Caselles, O; Courbon, F; Dierickx, L; Gabiache, E; Kanoun, S; Pascal, P; Sinigaglia, M; Tal, I; Vallot, D; Vija Racaru, L; Zerdoud, S	1
Abrantes, AM; Botelho, MF; Figueiredo, A; Marques, IA; Neves, AR; Pires, AS; Tavares-da-Silva, E	1
Bruland, ØS; Herlofson, BB; Kjølle, GK; Løndalen, AM; Westgaard, KL	1
Bottomley, D; Din, O; Dixit, S; Ferguson, C; Handforth, C; Henry, AM; Joseph, L; Kenning, L; Mokhtar, D; Murray, L; Parikh, S; White, L; Wright, G	1
Canelón Castillo, E; Díez Farto, S; Jiménez Romero, ME; Navarro Serrato, JS; Revelo Cadena, I	1
Etchebehere, E; Kairemo, K; Macapinlac, HA; Milton, DR; Rohren, EM	1
Garla, VV; Kovvuru, KR; Salim, S; Subauste, A	1
Álvarez-Ossorio, JL; Carballido-Rodríguez, J; Cozar-Olmo, JM; Gómez-Veiga, F; Juárez-Soto, A; Rodríguez-Antolín, A	1
Arranz, JÁ; Carles, J; Castellano, D; González Del Alba, A; Jimenez, J; López, C; Manneh, R; Mellado, B; Méndez-Vidal, MJ; Morales-Barrera, R; Perez-Gracia, JL; Porras, I; Saez, MI; Sepúlveda, JM; Suárez, C	1
Ferretti, A; Gross, MD; Rubello, D; Viglianti, BL; Wale, DJ; Wong, KK	1
Afshar-Oromieh, A; Ahmadzadehfar, H; Essler, M; Rahbar, K	1
Antonarakis, ES; Carducci, MA; Denmeade, SR; DeWeese, TL; Eisenberger, MA; Hassan, S; Isaacsson Velho, P; Markowski, MC; Qazi, F; Song, DY; Thorek, DL; Tran, PT	1
Camargo Ibargarai, I; Lacasa-Viscasillas, I; Loizaga-Iriarte, A; Senarriaga-Ruiz de la Illa, N; Unda-Urzaiz, M	1
Kratochwil, C; Levy, M; Lewington, V; Lindén, O; Noordzij, W; Park, J; Parker, C; Saad, F; Shore, N	1
Iizuka, J	1
Bryce, AH; Dorff, TB; Groshen, S; Ji, L; Quinn, DI; Wong, W; Yap, KK	1
Danson, S; Geva, R; Harris, SJ; Joensuu, H; Lopez, J; Peer, A; Pereira, KMC; Perets, R; Souza, F	1
Bloemendal, HJ; Bouman-Wammes, EW; de Klerk, JMH; Lange, R; Ter Heine, R; Van den Eertwegh, AJM; Van Dodewaard-de Jong, JM; Verheul, HMW	1
Guerra Liberal, FDC; McMahon, SJ; Moreira, HMR; O'Sullivan, JM; Prise, KM	1
Gerritsen, WR; Hermsen, R; Janssen, MJR; Mehra, N; van der Doelen, MJ; van Oort, IM	1
Carles, J; Gillessen, S; Heidenreich, A; Heinrich, D; Keizman, D; Miller, K; Nilsson, S; O'Sullivan, JM; Reeves, J; Saad, F; Seger, M; Wirth, M	2
Casarin, S; De-Juan-Pardo, EM; Dondossola, E; Friedl, P; Hutmacher, DW; Logothetis, CJ; Paindelli, C	1
Dondossola, E; Friedl, P; Logothetis, CJ; Navone, N; Paindelli, C	1
Anderson, PM; Benjamin, RS; Chawla, S; Daw, NC; Hess, K; Hong, DS; Huh, WW; Kairemo, K; Kleinerman, E; Ludwig, JA; Macapinlac, H; Meric-Bernstam, F; Ravi, V; Ravizzini, G; Rohren, E; Somaiah, N; Subbiah, V	1
Boegemann, M; Heidenreich, A; Higano, C; Kakehi, Y; Karyakin, O; Kimura, G; Krissel, H; Matsubara, N; Matveev, V; Miller, K; Nahas, WC; Ng, QS; Nolè, F; Parker, C; Piulats, JM; Rosenbaum, E; Saad, F; Shen, J; Smith, M; Teufel, M; Tombal, B; Wagner, V; Zhang, A; Zucca, LE	1
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Nava-Cabrera, MA; Rojas-Calderón, E	1
Den, RB; George, D; McNamara, M; Pieczonka, C	1
Boni, G; Monari, F	1
Akagawa, T; Fukasawa, S; Hosono, M; Kawasaki, Y; Kikukawa, H; Kimura, G; Kinuya, S; Kosaka, T; Masumori, N; Matsubara, N; Mizokami, A; Nagamori, S; Nasu, Y; Sugiyama, T; Uemura, H; Wakumoto, Y; Yamaguchi, I; Yokomizo, A; Yonese, J	1
Carolino, E; Dizdarevic, S; Gape, P; Jessop, M; Pereira, L; Roque, V; Sousa, E	1
Bellarosa, C; Cardano, R; Dionisi, V; Fanti, S; Ghedini, P; Monari, F; Morganti, AG; Rizzini, EL	1
Anand, A; Anand, M; Armstrong, AJ; Chin, BB; George, DJ; McNamara, MA; Oldan, J; Oyekunle, T; Ritz, M; Shantzer, L	1
Antonarakis, ES; Carrasquillo, JA; Deandreis, D; Fizazi, K; Higano, CS; Jacene, HA; Loriot, Y; Lu, C; Morris, MJ; Pandit-Taskar, N; Petrenciuc, O; Ryan, CJ; Shevrin, DH; Sweeney, CJ; Vesselle, H	1
Iijima, M; Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kawaguchi, S; Makino, T; Matsuo, S; Mizokami, A; Nakashima, K; Nohara, T; Shigehara, K; Yaegashi, H	1
Colasurdo, AP; Gallicchio, R; Guglielmi, G; Landriscina, M; Mainenti, PP; Mastrangelo, PA; Nardelli, A; Storto, G	1
Anand, M; Armstrong, AJ; Davies, C; Foo, WC; George, DJ; Gerber, D; Giannakakou, P; Gregory, SG; Gupta, S; Halabi, S; Healy, P; Kemeny, G; Leith, B; Ribar, T; Rothwell, C; Somarelli, JA; Spritzer, C; Ware, K; Wood, K; Zalutsky, MR; Zhang, J	1
Erdek, M; Sindhi, V	1
Cortesi, E; De Vincentis, G; Farcomeni, A; Follacchio, GA; Frantellizzi, V; Pani, A; Samaritani, R; Santini, D; Schinzari, G	1
Miranda, J; Pinto, Á; Viñal, D	1
Morgan, SC	1
Chittenden, SJ; Flux, GD; Gear, J; Murray, I; Parker, CC; Taprogge, J	1
van der Poel, H	1
Aro, JL; Dinning, SI; Leung, EY; Zuckier, LS	1
Aksnes, AK; Carrasquillo, JA; Humm, JL; Lacuna, K; Larson, SM; Morris, MJ; O'Donoghue, JA; Pandit-Taskar, N; Rathkopf, DE; Scher, HI; Slovin, SF; Williamson, MJ	1
Alhoniemi, E; Fagerlund, KM; Halleen, JM; Käkönen, R; Käkönen, SM; Mumberg, D; Rissanen, JP; Scholz, A; Suominen, MI; Ziegelbauer, K	1
Kantoff, PW; Mohler, JL	1
Boehmer, S; Bottomley, D; Bruland, ØS; Chodacki, A; Coleman, R; Dall'Oglio, M; Fosså, SD; Franzén, L; Garcia-Vargas, J; Heinrich, D; Helle, SI; Hoskin, P; James, ND; Johannessen, DC; Kliment, J; Logue, J; Nilsson, S; O'Bryan-Tear, CG; O'Sullivan, JM; Parker, C; Sartor, O; Seke, M; Shan, M; Solberg, A; Staudacher, K; Syndikus, I; Vogelzang, NJ; Wedel, S; Widmark, A; Wiechno, P	1
Glatstein, E; Vapiwala, N	2
Colletti, PM	1
Ha, YS; Joung, JY; Kim, IY	1
Gelderblom, H; van der Pluijm, G; van Leeuwen, FW; Wissing, MD	1
Grivas, PD; Keller, ET	1
Parker, C; Sartor, O	2
Biersack, HJ; Ezziddin, S; Knapp, FF	1
Ciezki, JP; Klein, EA; Tendulkar, RD; Ward, MC	1
Asabella, AN; Nicoletti, A; Rubini, D; Rubini, G	1
Al-Hakim, A; Alebachew, E; Chen, W; Haber, MT; Ibrahim, A; Justice, R; Kluetz, PG; Leutzinger, EE; Liu, Q; Maher, VE; Palmby, T; Pazdur, R; Pierce, W; Song, P; Sridhara, R; Tang, S; Zhang, H	1
Armstrong, AJ; Bahnson, RR; Cohen, M; D'Amico, AV; Eastham, JA; Enke, CA; Farrington, TA; Higano, CS; Ho, M; Horwitz, EM; Kantoff, PW; Kawachi, MH; Kuettel, M; Lee, RJ; Macvicar, GR; Malcolm, AW; Miller, D; Mohler, JL; Plimack, ER; Pow-Sang, JM; Richey, S; Roach, M; Rohren, E; Rosenfeld, S; Shead, DA; Small, EJ; Srinivas, S; Stein, C; Strope, SA; Tward, J; Walsh, PC	1
Carrasquillo, JA; Larson, SM; Pandit-Taskar, N	1
Giammarile, F	1
Taneja, SS	2
Aksnes, AK; Awadallah, R; Biggin, C; Carrasquillo, J; Dauer, LT; Ghani, R; Humm, J; Morris, M; O'Donoghue, J; Pandit-Taskar, N; Reinton, V; St Germain, J; Williamson, MJ	1
Higano, CS	1
Heinzer, H; Klutmann, S; König, F	1
McCormack, PL; Shirley, M	1
Aksnes, AK; Coleman, R; Flamen, P; Garcia, C; Jerusalem, G; Naume, B; Piccart, M; Thuresson, M; Vobecky, N	1
Den, RB; Doyle, LA; Knudsen, KE	1
Bruland, ØS; Chodacki, A; Coleman, R; Fosså, SD; Heinrich, D; Helle, SI; Hoskin, P; James, ND; Johannessen, DC; Logue, J; Nilsson, S; O'Bryan-Tear, CG; O'Sullivan, JM; Parker, C; Sartor, O; Shan, M; Solberg, A; Syndikus, I; Vogelzang, NJ; Widmark, A; Wiechno, P	1
Logothetis, CJ	1
Roach, M	1
Nilsson, S	3
Anderson, PM; Rohren, E; Subbiah, V	1
Boni, G; Borsò, E; Cianci, C; Falcone, A; Farnesi, A; Galli, L; Mariani, G; Mazzarri, S; Ricci, S	1
Gartrell, BA; Saad, F	1
O'Sullivan, J; Turner, PG	1
Everly, JJ; Ryan, CJ; Sartor, O; Saylor, PJ	1
Géczi, L; Sinkovics, I	1
Højgaard, L; Mortensen, J	1
Guerra Liberal, FD; Tavares, AA; Tavares, JM	1
Den, RB; Kelly, WK	1
Aksnes, AK; Bottomley, D; Fang, F; Helle, SI; Hoskin, P; Johannessen, DC; Logue, J; Nilsson, S; O'Sullivan, JM; Parker, C; Sartor, O; Vogelzang, NJ; Wahba, M	1
Bjøro, T; Bogsrud, TV; Fosså, SD; Hernes, E; Nome, R	1
Baba, S; Honda, H; Nakamura, K; Ohga, S; Sasaki, T	1
Afonso Afonso, FJ; Anido Herranz, U; Antón Aparicio, LM; Fernández Calvo, O; Lázaro Quintela, M; León Mateos, L; Rodríguez Martínez de Llano, S; Vázquez Estévez, S	1
Horton, ER; McGann, S	1
Bilusic, M; Chen, D; Ito, T	1
Shore, ND	2
Slovin, SF; Yeku, O	1
Challa, S; Conti, PS; Jadvar, H; Quinn, DI	1
Hall, NC; Monk, JP; Murrey, DA; Wright, CL	1
O'Sullivan, JM; Turner, PG	1
Bergeron, DE; Cessna, JT; Fitzgerald, R; King, L; Pibida, L; Zimmerman, B	1
Bruland, OS; Humm, JL; Macklis, R; Parker, C; Sartor, O	1
George, DJ; McNamara, MA	1
Dorff, TB; Gross, ME	1
Araujo, JC; Etchebehere, EC; Fox, PS; Macapinlac, HA; Rohren, EM; Swanston, NM	1
Beer, TM; Graff, JN	1
Body, JJ; Casimiro, S; Costa, L	1
Coleman, R; Efstathiou, E; Fizazi, K; Gartrell, BA; Logothetis, CJ; Saad, F; Sartor, O; Smith, MR; Sonpavde, G	1
Chalhoub, E; Chalouhy, C; Lewis, B; Sartor, O	1
Bilen, MA; Lin, SH; Tu, SM	1
Chittenden, SJ; Flux, GD; Hindorf, C; Johnson, B; Lewington, VJ; Parker, CC; Pratt, BE	1
Siegel, JA; Stabin, MG	1
Bienz, M; Saad, F	1
Cassano, B; De Vincentis, G; Di Castro, E; Follacchio, GA; Frantellizzi, V; Garkavaya, T; Ialongo, P; Lorenzon, L; Mango, L; Pacilio, M; Pani, R; Pellegrini, R; Ventroni, G	1
Besenyi, Z; Pávics, L	1
Armstrong, AJ; Li, J	1
Makis, W; McCann, K; McEwan, AJ; Sawyer, MB	1
Bloemendal, HJ; de Klerk, JM; Hoekstra, OS; Hooft, L; Jong, JM; Oprea-Lager, DE; van den Eertwegh, AJ; Verheul, HM	1
Baqué, PE; Beck, J; Hampel, C; Helisch, A; Krieger, C; Miederer, M; Schreckenberger, M; Thomas, C	1
Chowdhury, S; Gilson, C; Kirby, R; Manickavasagar, T	1
Adams, S; Paryani, B; Subbiah, V; Takalkar, A	1
Cassano, B; Di Castro, E; Ialongo, P; Lorenzon, L; Mango, L; Pacilio, M; Recine, F; Sternberg, CN; Ventroni, G	1
Abou, DS; Doucet, M; Hobbs, RF; Riddle, RC; Thorek, DL; Ulmert, D	1
Kirchner, V; Papazyan, JP	1
Knight, H; McVeigh, G; Umeweni, N	1
Araujo, JC; Erwin, WD; Etchebehere, EC; Fox, P; Macapinlac, HA; Milton, DR; Rohren, EM; Swanston, NM; Wendt, RE	1
Coleman, R	1
Bertaglia, V; Buttigliero, C; Di Maio, M; Scagliotti, GV; Tucci, M; Vignani, F	1
Ahmadzadehfar, H; Essler, M; Gaertner, F; Schlenkhoff, CD; Schmidt, M	1
Cislo, P; Coleman, RE; Nilsson, S; O'Sullivan, JM; Parker, C; Reuning-Scherer, J; Sartor, O; Shan, M; Vogelzang, NJ; Zhan, L	1
Coleman, RE; Hoskin, P; Nilsson, S; Parker, C; Petrenciuc, O; Sartor, O; Staudacher, K; Thuresson, M; Vogelzang, NJ	1
Dellavedova, L; Florimonte, L; Maffioli, LS	1
Cortesi, E; De Vincentis, G; Follacchio, GA; Frantellizzi, V; Liberatore, M; Monteleone, F	1
Hino, A; Inoue, T; Kaneko, M; Kaneta, T; Kawano, T; Shizukuishi, K; Sugiura, M; Takano, S; Yamamoto, T; Yoshida, K; Zurth, C	1
Bottomley, D; Bruland, Ø; Coleman, RE; Finkelstein, SE; Li, R; Michalski, JM; Nilsson, S; O'Sullivan, JM; Parker, C; Sartor, O; Seger, MA; Vogelzang, NJ	1
Dan, TD; Den, RB; Doyle, L; Gomella, LG; Pridjian, A; Raval, AJ	1
Barkin, J	1
Dermine, A; Machiels, JP	1
Ahmadzadehfar, H; Essler, M; Rogenhofer, S; Schlenkhoff, CD; Yordanova, A	1
Andreeff, M; Becherer, A; Bockisch, A; Fricke, E; Gabriel, M; Geworski, L; Heinzel, A; Krause, BJ; Krause, T; Mitterhauser, M; Pöppel, TD; Scheidhauer, K; Schenck, M; Sonnenschein, W	1
Carles, J; Federhofer, J; Gillessen, S; Gratt, J; Heidenreich, A; Heinrich, D; Lévy, J; Miller, K; Nilsson, S; O'Sullivan, JM; Petrenciuc, O; Saad, F; Tucci, M; Wirth, M	1
Dahut, WL; Gulley, JL; Madan, RA	1
Parker, C; Wilson, JM	1
Thoma, C	1
Aarts, MJ; Badrising, SK; Bergman, AM; Coenen, JL; de Jong, IJ; Gelderblom, H; Haanen, JB; Hamberg, P; Kerver, ED; Los, M; van den Berg, HP; van den Eertwegh, AJ; van der Noort, V; van Oort, IM; van Voorthuizen, T; Vrijaldenhoven, S	1
Edwards, CM; Turner, CJ	1
Coleman, RE; Germino, J; Michalski, JM; Nilsson, S; O'Sullivan, JM; Parker, C; Sartor, O; Thuresson, M; Vogelzang, NJ; Widmark, A; Xu, L	1
Alho, I; Casimiro, S; Costa, L; Ferreira, AR; Mansinho, A	1
Ahmadzadehfar, H; Azgomi, K; Essler, M; Gaertner, FC; Hauser, S; Kürpig, S; Strunk, H; Wei, X; Yordanova, A	1
Cotogno, P; Ledet, EM; Lewis, B; Sartor, O; Steinberger, AE	1
Aprile, C; Buroni, FE; Lodola, L; Nano, R; Pasi, F; Persico, MG	1
Miyahira, AK; Morris, M; Soule, HR	1
Baiocco, C; Genovese, S; Poti, C; Scalzi, P; Sirotova, Z; Trevisan, A	1
Cislo, P; Coleman, RE; Nilsson, S; O'Sullivan, JM; Parker, C; Reuning-Scherer, J; Sartor, O; Vogelzang, NJ; Zhan, L	1
Gunturu, K; Kewalramani, T; Tretter, C; Varkaris, A	1
Eiber, M; Gschwend, J; Krönke, M; Scheidhauer, K; Tauber, R	1
Ágoston, P; Bíró, K; Böde, I; Bodrogi, I; Dank, M; Géczi, L; Gyergyay, F; Kolonics, Z; Küronya, Z; Nagyiványi, K; Rúzsa, Á; Sinkovics, I; Vajdics, T	1
Odo, U; Sartor, O; Vasudevamurthy, AK	1
Airoldi, M; Angusti, T; Buttigliero, C; Manfredi, M; Parente, A; Tucci, M	1
Alibhai, SMH; Emmenegger, U; Finelli, A; Hotte, SJ; Morgan, SC; Walker-Dilks, C; Winquist, E; Zukotynski, K	1
Cathomas, R; Daugaard, G; Desax, MC; Dresler, H; Fosboel, MO; Gillessen, S; Gottfried, M; Keizman, D; Mermershtain, W; Mortensen, J; Mueller, J; Neiman, V; Omlin, A; Peer, A; Petersen, PM; Reichegger, H; Rosenbaum, E; Rouvinov, K; Sarid, D	1
Liepe, K	1
Kamoto, T	1
Flux, GD; Hindorf, C; Ibisch, C; Kraeber Bodéré, F	1
Agarwal, N; Sonpavde, G; Sternberg, CN	1
Aksnes, AK; Andersson, C; Bruland, ØS; Franzèn, L; Nilsson, S; Olivier, P; Pecking, A; Staffurth, J; Strang, P; Vasanthan, S	1
Lewis, B; Sartor, O	1
Mackiewicz-Wysocka, M; Pankowska, M; Wysocki, PJ	1
Aksnes, AK; Chittenden, S; Flux, GD; Hindorf, C; Parker, C	1
Cheetham, PJ; Petrylak, DP	1
Chang, AJ; Roach, M	1
Silberstein, EB	1
O'Sullivan, JM; Parker, CC; Vengalil, S	1
Brugge, D; Buchner, V	1
Badawi, JK	1
Buscombe, J; Navalkissoor, S	1
Chodacki, A; Germá, JR; Haider, T; Hoskin, P; O'Bryan-Tear, CG; O'Sullivan, JM; Parker, CC; Pascoe, S	1
Blom, R; Bolstad, B; Bruland, ØS; Franzén, L; Johannessen, DC; Lennernäs, B; Nilsson, S; O'Bryan-Tear, CG; Parker, C; Petersson, U; Pigott, K; Sokal, M; Tennvall, J; Thuresson, M; Tyrrell, C	1
Bellmunt, J	1
Croke, J; Leung, E; Malone, S; Segal, R	1
Armstrong, AJ; Fizazi, K; Freedland, S; Pienta, K; Saad, F; Saylor, PJ; Smith, MR; Tombal, B	1
Hafeez, S; Parker, C	1
Kerr, C	1
Bijwaard, H; Brugmans, MJ; Leenhouts, HP	2
Harrison, JD; Muirhead, CR	1
Bowman, BM; Lloyd, RD; Miller, SC; Taylor, GN	1
MARINELLI, LD	1
POPPE, H; SCHOEN, H; SPIESS, H	1
WOODARD HQ HIGINBOTHAM, NL	1
SPIERS, FW	3
DAHLIN, DC; HOLTZMAN, RB; LUCAS, HF	2
JANOWER, ML	1
NAHUM, AM	1
BEAL, DD; LINDSAY, JR; WARD, PH	1
FINKEL, AJ; HASTERLIK, RJ; MILLER, CE	2
BRIGHTON, CT; BUNDENS, WD	1
Gössner, W	6
HOECKER, FE; ROOFE, PG	1
AUERBACH, H	1
Heidenreich, WF; Müller, WA; Paretzke, HG; Rosemann, M	1
Balteskard, L; Borch, KW; Bruland, OS; Fosså, SD; Larsen, RH; Nilsson, S; Salberg, G; Westlin, JE	1
Bruenger, FW; Jee, WS; Lloyd, RD; Miller, SC; Taylor, GN	3
Altavilla, G; Aricò, D; Baldari, S; Herberg, A; Minutoli, F; Restifo Pecorella, G; Spadaro, P	1
Bruland, ØS; Fisher, DR; Larsen, RH; Nilsson, S	1
Bijwaard, H	1
Berdon, WE; Liebling, MS; Marcovici, PA	1
Blom, R; Bolstad, B; Bruland, OS; Franzén, L; Garkavij, M; Harmenberg, J; Johannessen, DC; Lennernäs, B; Nilsson, S; Parker, C; Petersson, U; Pigott, K; Sokal, M; Strang, P; Tennvall, J; Tyrrell, C; Yachnin, J	1
Mason, MD; Shelley, MD	1
Amaral, A; Amaral, RS; Silva, CM	1
Hems, G	2
Raabe, OG	2
Gössner, W; Luz, A; Müller, WA; Schäffer, EH	1
Beddoe, AH; Spiers, FW	1
Filiushkin, IV; Petoian, IM	1
Luz, A; Schoeters, GE; Vanderborght, OL	1
Atherton, DR; Ayoroa, G; Brammer, D; Brammer, TW; Gardner, PA; Lloyd, RD; Mays, CW; McFarland, SS; Pollard, TA; Talbot, LR; Taylor, GN; Taysum, DH; VanMoorhem, D	1
Bruenger, FW; Jones, CW; Lloyd, RD; Mays, CW; Taylor, GN	1
Sharpe, WD	3
Henning, CB; Lloyd, EL	1
Lucas, HF; Rowland, RE; Stehney, AF	2
Gössner, W; Wick, RR	1
Book, SA; Parks, NJ; Raabe, OG	3
Kirsh, IE; Morgan, JP; Pool, RR	1
Angus, W; Atherton, DR; Mays, CW; Shabestari, L; Taylor, GN; Thurman, GB	1
Book, SA; Chrisp, CE; Goldman, M; Parks, NJ; Raabe, OG	1
Finkelstein, MM	1
Angus, W; Bruenger, FW; Jee, WS; Lloyd, RD; Miller, SC; Taylor, GN	1
Culbertson, MR; Parks, NJ; Raabe, OG; Rosenblatt, LS; Samuels, SJ; White, RG	1
Lloyd, RD	1
Finkelstein, MM; Kreiger, N	1
Boecker, BB; Griffith, WC; Hahn, FF; Lloyd, RD; Muggenburg, BA	1
Carnes, BA; Groer, PG; Kotek, TJ	1
Jee, WS; Li, XJ; Lloyd, RD; Mays, CW; Miller, SC; Mori, S; Shabestari, L; Taylor, GN	1
Lloyd, RD; Miller, SC; Taylor, GN; Thurman, GB	1
Fry, SA	1
Jee, WS; Lloyd, RD; Miller, SC; Taylor, GN	1
Fisher, DR; Lloyd, RD; Miller, SC; Schlenker, RA	1
Eder, E; Kellerer, AM; Kuse-Isingschulte, M; Nekolla, EA; Spiess, H	1
Gössner, W; Kellerer, AM; Nekolla, EA; Wick, RR	1
Gössner, W; Kellerer, AM; Kreisheimer, M; Kuse-Isingschulte, M; Nekolla, EA; Spiess, H	1
Brugmans, MJ; Leenhouts, HP	1
Lloyd, RD; Miller, SC; Taylor, GN	1
Fisher, DR; Lloyd, RD; Miller, SC; Schlenker, RA; Taylor, GN	1
Chadwick, KH	1
Breistøl, K; Bruland, ØS; Fodstad, Ø; Henriksen, G; Larsen, RH	1
Gössner, W; Hug, O; Luz, A; Müller, WA	3
Thorne, MC	1
Luz, A; Müller, WA	1
Bubeniková, D; Dvorák, V; Kofránek, V; Kotasková, Z; Svoboda, V	1
Bubeníková, D; Kofránek, V; Machek, J; Parízek, O; Svoboda, V	1
Beddoe, AH; King, SD; Spiers, FW	1
Mays, CW	3
Mole, RH	1
Momeni, MH	1
Brady, LW	1
Mays, CW; Spiess, H	4
Polednak, AP	1
Brues, AM; Keane, AT; Littman, MS; Patten, BC; Rowland, RE; Shanahan, MM; Stehney, AF	1
Spiers, FW; Vaughan, J	1
Groer, PG; Marshall, JH	1
Ardran, GM; Corp, MJ; Loutit, JF	1
Lloyd, EL; Loutit, JF; Mackevicius, F	1
Atkinson, MJ; Erfle, V; Gössner, W; Linzner, U; Luz, A; Müller, K; Müller, WA; Murray, AB; Schmidt, J; Strauss, PG	1
Raabe, OG; Rosenblatt, LS; Schlenker, RA	1
Chmelevsky, D; Kellerer, AM; Spiess, H	1
Angus, W; Bruenger, FW; Jee, WS; Lloyd, RD; Miller, SC; Polig, E; Taylor, GN	1
Bruenger, FW; Lloyd, RD; Miller, SC	1
Maisin, JR; Schoeters, GE; Vanderborght, OL	1
Chmelevsky, D; Kellerer, AM; Mays, CW; Spiess, H	2
Linzner, U; Luz, A; Müller, WA; Murray, AB	1
Erfle, V; Luz, A; Schmidt, J	1
Priest, ND	1
Lloyd, RD; Mays, CW; Taylor, GN; Wrenn, ME	1
Bubeníková, D; Dvorák, V; Kofránek, V; Sedlák, A	1
Mays, CW; Rowland, RE; Stehney, AF	1
Durbin, PW; Howard, B; Lipsztein, J; Rundo, J; Still, ET; Willis, DL; Wrenn, ME	1
Jones, CW; Lloyd, RD; Mays, CW; McFarland, SS; Packer, SM; Smith, JM; Taylor, GN	1
Keane, AT; Lucas, HF; Rundo, J; Schlenker, RA; Stebbings, JH; Stehney, AF	1
Chmelevsky, D; Kellerer, A; Mays, CW; Spiess, H	1
Chmelevsky, D; Gössner, W; Wick, RR	1
Dell, RB; Jee, WS; Miller, SC; Parks, NJ	1
Luz, A; Müller, WA; Schäffer, EH	1
Becker, G; Lepp, C; Luz, A; Pömsl, H	1
Kondrat'eva, AF	1
Hutchison, GB	1
Gössner, W; Hindringer, B; Hug, O; Luz, A; Müller, WA	1
Eschwège, F; Le Bourgeois, JP; Schlienger, M	1
Blair, HA	2
Pesternikov, VM	1
Marquart, KH	1
Holusa, R; Kofrånek, V; Onyskowovå, Z	1
Rowland, RE; Rundo, J	1
Piller, S	1
Gössner, W; Hindringer, B; Luz, A	1
Dalinka, MK; Edeiken, J; Finkelstein, JB	1
Abrahams, SP; Lucas, HF; Petersen, NJ; Samuels, LD	1
Murphy, WT	1
Evans, RD	1
Loutit, JF	1
Dougherty, TF; Jee, WS; Mays, CW; Taylor, GN	1
Gofman, JW; Tamplin, AR	1
Gridgeman, NT	1
Arlen, M; Higinbotham, NL; Huvos, AG; Marcove, RC; Miller, T; Shah, IC	1
Globocnik, E; Kofránek, V; Svoboda, V	1
Müller, WA	1
Bernier, L; Delage, C	1
Bulgin, MS; Goldman, M; Williams, RJ	1
Goss, SG	1
Kratochwil, A; Tatra, G	1
Evans, RD; Finkel, AJ; Hasterlik, RJ; Keane, AT; Kolenkow, RJ; Neal, WR; Shanahan, MM	1
Boyd, JT; Doll, R; Hill, GB; Sissons, HA	1
Hems, G; Mole, RH	1
CHARKES, ND; SKLAROFF, DM	1

Reviews

111 review(s) available for radium and Bone Neoplasms

Article	Year
RADIONUCLIDE THERAPY FOR BONE LESIONS IN CASTRATION-RESISTANT PROSTATE CANCER (STATE-OF-THE-ART LITERATURE REVIEW). Problemy radiatsiinoi medytsyny ta radiobiolohii, 2022, Volume: 27 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium	2022
Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summary. Future oncology (London, England), 2023, Volume: 19, Issue:15 Topics: Bone Neoplasms; Docetaxel; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2023
The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis. International journal of molecular sciences, 2019, Aug-10, Volume: 20, Issue:16 Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Humans; Molecular Targeted Therapy; Osteoblasts; Osteoclasts; Prognosis; Radioisotopes; Radium	2019
Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:1 Topics: Actinium; Astatine; Bismuth; Bone Neoplasms; Humans; Lead Radioisotopes; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Thorium	2020
[Radium-223 for the treatment of metastatic castration-resistant prostate cancer (mCRPC) : The androgen receptor-independent active agent in the therapeutic sequence]. Der Urologe. Ausg. A, 2020, Volume: 59, Issue:1 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radiopharmaceuticals; Radium; Receptors, Androgen	2020
Radium-223 mechanism of action: implications for use in treatment combinations. Nature reviews. Urology, 2019, Volume: 16, Issue:12 Topics: Animals; Bone Neoplasms; Combined Modality Therapy; Disease Models, Animal; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review. Critical reviews in oncology/hematology, 2020, Volume: 146 Topics: Androstenes; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Docetaxel; Humans; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome; Tumor Microenvironment	2020
Radium-223 as an Approved Modality for Treatment of Bone Metastases. Seminars in nuclear medicine, 2020, Volume: 50, Issue:2 Topics: Bone Neoplasms; Drug Approval; Humans; Isotope Labeling; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2020
Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer. Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:7 Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Neoplasms; Chemoradiotherapy; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome; Tumor Microenvironment	2020
Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer. Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:7 Topics: Alpha Particles; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Chemoradiotherapy; Humans; Male; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Treatment Outcome	2020
Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies. Current osteoporosis reports, 2021, Volume: 19, Issue:4 Topics: Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Humans; Radiopharmaceuticals; Radium; Zoledronic Acid	2021
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel. Critical reviews in oncology/hematology, 2017, Volume: 113 Topics: Bone Neoplasms; Disease Management; Docetaxel; Humans; Italy; Male; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Taxoids; Treatment Outcome	2017
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:9 Topics: Antineoplastic Agents; Bone Neoplasms; Disease-Free Survival; Humans; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic	2017
Therapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines. International journal of urology : official journal of the Japanese Urological Association, 2017, Volume: 24, Issue:8 Topics: Abiraterone Acetate; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Disease Progression; Docetaxel; Humans; Japan; Male; Neoplasm Recurrence, Local; Nitriles; Phenylthiohydantoin; Prognosis; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids	2017
The role of bone-targeted therapies for prostate cancer in 2017. Current opinion in supportive and palliative care, 2017, Volume: 11, Issue:3 Topics: Androstenes; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Male; Prospective Studies; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Zoledronic Acid	2017
Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases. Expert review of clinical pharmacology, 2017, Volume: 10, Issue:8 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Survival Rate; Treatment Outcome	2017
Imaging and dosimetry for radium-223: the potential for personalized treatment. The British journal of radiology, 2017, Volume: 90, Issue:1077 Topics: Bone Neoplasms; Humans; Male; Precision Medicine; Prostatic Neoplasms; Radioisotopes; Radiometry; Radium	2017
Radium-223 in the therapeutic sequence of metastatic castration-resistant prostate cancer. Actas urologicas espanolas, 2018, Volume: 42, Issue:4 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2018
[Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts]. Bulletin du cancer, 2017, Volume: 104, Issue:9 Topics: Alpha Particles; Beta Particles; Bone Neoplasms; Cancer Pain; Clinical Trials as Topic; Gamma Rays; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2017
Radium 223 dichloride for prostate cancer treatment. Drug design, development and therapy, 2017, Volume: 11 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; DNA Breaks, Double-Stranded; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Tumor Microenvironment	2017
[Radium-223 dichloride in patients with castration-refractory prostate cancer]. Der Urologe. Ausg. A, 2017, Volume: 56, Issue:11 Topics: Androstenes; Benzamides; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Denosumab; Humans; Male; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment	2017
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer. Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:11 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Treatment Outcome	2017
Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018, Volume: 20, Issue:6 Topics: Bone Neoplasms; Humans; Male; Patient Selection; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium	2018
Targeted α Therapies for the Treatment of Bone Metastases. International journal of molecular sciences, 2017, Dec-28, Volume: 19, Issue:1 Topics: Alpha Particles; Bone Neoplasms; Brachytherapy; Dose-Response Relationship, Radiation; Humans; Male; Practice Guidelines as Topic; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic	2017
Current approaches to incorporation of radium-223 in clinical practice. Prostate cancer and prostatic diseases, 2018, Volume: 21, Issue:1 Topics: Androstenes; Benzamides; Bone Neoplasms; Docetaxel; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Receptors, Androgen; Taxoids; Treatment Outcome	2018
Current perspectives on bone metastases in castrate-resistant prostate cancer. Cancer metastasis reviews, 2018, Volume: 37, Issue:1 Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant; Radium; Tumor Microenvironment; Xenograft Model Antitumor Assays	2018
Prostate cancer - Therapy with radium-223. Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:12 Topics: Antineoplastic Agents; Bone Neoplasms; Brazil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Evidence-Based Medicine; Humans; Male; Placebos; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiotherapy Dosage; Radium; Randomized Controlled Trials as Topic; Risk Factors; Societies, Scientific; Survival Rate	2017
[Radium-223 for the treatment of bone metastasis of prostate cancer]. Zhonghua nan ke xue = National journal of andrology, 2017, Volume: 23, Issue:1 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radium	2017
Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations. Clinical genitourinary cancer, 2018, Volume: 16, Issue:4 Topics: Bone Neoplasms; Clinical Trials, Phase III as Topic; Hematologic Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Treatment Outcome	2018
The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer. Cancer treatment reviews, 2018, Volume: 68 Topics: Abiraterone Acetate; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Clinical Trials, Phase III as Topic; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Taxoids; Zoledronic Acid	2018
Targeted alpha therapy using Radium-223: From physics to biological effects. Cancer treatment reviews, 2018, Volume: 68 Topics: Alpha Particles; Animals; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2018
Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity. Actas urologicas espanolas, 2018, Volume: 42, Issue:10 Topics: Abdominal Neoplasms; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Time Factors; Viscera	2018
Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma. American journal of clinical oncology, 2019, Volume: 42, Issue:1 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Lutetium; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium	2019
Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 2018, Volume: 13, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pain; Patient Care Planning; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium	2018
Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review. JAMA oncology, 2018, 12-01, Volume: 4, Issue:12 Topics: Alpha Particles; Bone Neoplasms; Humans; Male; Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiotherapy; Radium; Therapies, Investigational	2018
Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging. Asia-Pacific journal of clinical oncology, 2018, Volume: 14 Suppl 5 Topics: Bone Neoplasms; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium; Tomography, X-Ray Computed; Treatment Outcome	2018
Bone-Targeting Radiopharmaceuticals as Monotherapy or Combined With Chemotherapy in Patients With Castration-Resistant Prostate Cancer Metastatic to Bone. Clinical genitourinary cancer, 2019, Volume: 17, Issue:2 Topics: Bone Neoplasms; Cancer Pain; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Survival Analysis; Treatment Outcome	2019
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives. Clinical genitourinary cancer, 2019, Volume: 17, Issue:2 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Patient Selection; Practice Guidelines as Topic; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2019
Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection. American journal of clinical oncology, 2019, Volume: 42, Issue:4 Topics: Bone Neoplasms; Disease Management; Humans; Male; Patient Selection; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Tumori, 2019, Volume: 105, Issue:5 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Samarium; Strontium Radioisotopes	2019
Interventional treatments for metastatic bone cancer pain. Pain management, 2019, Volume: 9, Issue:3 Topics: Analgesics, Opioid; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Humans; Pain Management; Radium	2019
Radium 223 for the treatment of metastatic castration-resistant prostate cancer. Archivos espanoles de urologia, 2019, Volume: 72, Issue:5 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium	2019
Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice. Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiobiology; Radiopharmaceuticals; Radium	2019
Safe Use of Radium-223 Dichloride ( Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Exposure; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Safety Management; Tissue Distribution	2019
New developments in the management of prostate cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 2013, Volume: 11, Issue:5 Suppl Topics: Androgens; Antineoplastic Agents; Bone Neoplasms; Humans; Immunotherapy; Male; Prostatic Neoplasms; Radioisotopes; Radium; Salvage Therapy; Signal Transduction	2013
Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-01, Volume: 19, Issue:21 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Drug Approval; Drug Evaluation, Preclinical; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium	2013
Future directions from past experience: a century of prostate radiotherapy. Clinical genitourinary cancer, 2014, Volume: 12, Issue:1 Topics: Bone Neoplasms; Brachytherapy; History, 20th Century; History, 21st Century; Humans; Male; Prostate; Prostatic Neoplasms; Proton Therapy; Radioisotopes; Radiotherapy, Adjuvant; Radium; Salvage Therapy	2014
Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:1 Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium	2014
Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:2 Topics: Alpha Particles; Animals; Antineoplastic Agents; Bone Neoplasms; Humans; Neoplasm Metastasis; Neoplasms; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Radioisotopes; Radiometry; Radiopharmaceuticals; Radium; Strontium	2014
[Bone metastases treated with radiopharmaceuticals]. Bulletin du cancer, 2013, Volume: 100, Issue:11 Topics: Analgesics; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Strontium; Strontium Radioisotopes	2013
[Alpha emitter radium-223 dichloride: new therapy in castration-resistant prostate cancer with symptomatic bone metastases]. Der Urologe. Ausg. A, 2014, Volume: 53, Issue:4 Topics: Alpha Particles; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Cooperative Behavior; Dose-Response Relationship, Radiation; Humans; Interdisciplinary Communication; Male; Palliative Care; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate	2014
Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases. Drugs, 2014, Volume: 74, Issue:5 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prognosis; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Survival Rate	2014
Practical guide to the use of radium 223 dichloride. The Canadian journal of urology, 2014, Volume: 21, Issue:2 Supp 1 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate; Treatment Outcome	2014
Alpha-emitter radium-223 in the management of solid tumors: current status and future directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2014 Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2014
Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223. Advances in experimental medicine and biology, 2014, Volume: 804 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Lung Neoplasms; Molecular Targeted Therapy; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate	2014
Pathologic fracture in patients with metastatic prostate cancer. Current opinion in urology, 2014, Volume: 24, Issue:6 Topics: Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Zoledronic Acid	2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data. The oncologist, 2014, Volume: 19, Issue:10 Topics: Alpha Particles; Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Fractures, Spontaneous; Humans; Male; Pain Management; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium	2014
[Bone-targeted treatment in prostate cancer]. Magyar onkologia, 2014, Volume: 58, Issue:3 Topics: Alkaline Phosphatase; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radium; Randomized Controlled Trials as Topic; RANK Ligand; Treatment Outcome	2014
[Radium-223 treatment of bone metastases from castration-resistant prostate cancer]. Ugeskrift for laeger, 2014, Jul-21, Volume: 176, Issue:30 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiometry; Radium	2014
[Targeted radionuclide therapy for castration-resistant prostate cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2014, Volume: 72, Issue:12 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Strontium Radioisotopes	2014
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer. Expert review of anticancer therapy, 2015, Volume: 15, Issue:3 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate	2015
Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:4 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; United States; United States Food and Drug Administration	2015
Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective. Urology, 2015, Volume: 85, Issue:4 Topics: Antineoplastic Agents; Attitude of Health Personnel; Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Patient Education as Topic; Patient Selection; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Urology	2015
Metabolism and pharmacokinetics of radium-223 in prostate cancer. Expert opinion on drug metabolism & toxicology, 2015, Volume: 11, Issue:5 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Precision Medicine; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Survival Rate	2015
(223)Ra and other bone-targeting radiopharmaceuticals-the translation of radiation biology into clinical practice. The British journal of radiology, 2015, Volume: 88, Issue:1050 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Linear Energy Transfer; Palliative Care; Radiobiology; Radioisotopes; Radiopharmaceuticals; Radium; Translational Research, Biomedical	2015
Radium-223 in the treatment of osteoblastic metastases: a critical clinical review. International journal of radiation oncology, biology, physics, 2015, Apr-01, Volume: 91, Issue:5 Topics: Alpha Particles; Animals; Beta Particles; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Colon; DNA Breaks, Double-Stranded; Female; Gastrointestinal Tract; Half-Life; Humans; Male; Mice; Multiple Myeloma; Neoplasms, Second Primary; Osteogenesis; Osteosarcoma; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiologic Health; Radionuclide Imaging; Radium; Rats; Relative Biological Effectiveness; Tissue Distribution	2015
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:6 Topics: Androgen Receptor Antagonists; Androstenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Denosumab; Diphosphonates; Enzyme Inhibitors; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Pain; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Spinal Cord Compression; Zoledronic Acid	2015
Targeting bone metastases in prostate cancer: improving clinical outcome. Nature reviews. Urology, 2015, Volume: 12, Issue:6 Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Male; Osteoblasts; Osteolysis; Pain; Prognosis; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome; Zoledronic Acid	2015
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options. European urology, 2015, Volume: 68, Issue:5 Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Prostatic Neoplasms; Radioisotopes; Radium; Zoledronic Acid	2015
Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:7 Topics: Alkaline Phosphatase; Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Radium	2015
Management of bone metastases in prostate cancer: a review. Current opinion in supportive and palliative care, 2015, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Zoledronic Acid	2015
[Nuclear medicine in oncotherapy]. Magyar onkologia, 2015, Volume: 59, Issue:3 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Neoplasms; Humans; Interdisciplinary Communication; Iodine Radioisotopes; Liver Neoplasms; Medical Oncology; Neuroendocrine Tumors; Nuclear Medicine; Prevalence; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radium; Receptors, Somatostatin; Thyroid Neoplasms	2015
Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review. European urology, 2016, Volume: 70, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Cancer Pain; Etidronic Acid; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Strontium; Strontium Radioisotopes	2016
Treatment of Metastatic Bone Disease and the Emerging Role of Radium-223. Seminars in nuclear medicine, 2016, Volume: 46, Issue:2 Topics: Animals; Bone Neoplasms; Breast Neoplasms; Humans; Radium	2016
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer treatment reviews, 2016, Volume: 44 Topics: Androstenes; Anilides; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Dasatinib; Denosumab; Diphosphonates; Docetaxel; Humans; Imidazoles; Male; Mitoxantrone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Pyridines; Radioisotopes; Radium; Taxoids; Zoledronic Acid	2016
Radium-223 dichloride in clinical practice: a review. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:10 Topics: Bone Neoplasms; Comorbidity; Evidence-Based Medicine; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiation Injuries; Radioisotopes; Radiopharmaceuticals; Radium; Survival Rate; Treatment Outcome	2016
Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases. Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:4 Suppl 5 Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Humans; Male; Prednisone; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Treatment Outcome	2016
Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC). Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:4 Suppl 5 Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment; Treatment Outcome	2016
Phase II Clinical Study of Radium-223 Chloride (BAY 88-8223) in Japanese Patients With Symptomatic Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases. Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:4 Suppl 5 Topics: Antineoplastic Agents; Biomarkers; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2016
Treatment landscape of metastatic prostate cancer: the role of radium-223. Acta clinica Belgica, 2017, Volume: 72, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium	2017
The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer. Expert review of anticancer therapy, 2016, Volume: 16, Issue:9 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Survival Rate; Treatment Outcome	2016
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease. Current osteoporosis reports, 2016, Volume: 14, Issue:5 Topics: Adipocytes; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Bone and Bones; Bone Density Conservation Agents; Bone Marrow Cells; Bone Neoplasms; Carcinoma; Denosumab; Diphosphonates; Humans; Male; Mesenchymal Stem Cells; Molecular Targeted Therapy; Osteoblasts; Osteoclasts; Prostatic Neoplasms; Radioisotopes; Radium; Tumor Microenvironment	2016
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside? International journal of molecular sciences, 2016, Aug-27, Volume: 17, Issue:9 Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Female; Humans; Male; Radium	2016
Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer. Anticancer research, 2016, Volume: 36, Issue:11 Topics: Bone Neoplasms; Economics, Pharmaceutical; Humans; Male; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium	2016
Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223. The Prostate, 2017, Volume: 77, Issue:3 Topics: Bone Neoplasms; Clinical Trials as Topic; Congresses as Topic; Foundations; Humans; Male; New York City; Prostatic Neoplasms; Radioisotopes; Radium; Research Report	2017
Radium-223 Therapy of Bone Metastases in Prostate Cancer. Seminars in nuclear medicine, 2016, Volume: 46, Issue:6 Topics: Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Humans; Male; Prostatic Neoplasms; Radium	2016
Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care - Cancer Care Ontario Clinical Practice Guideline. Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, Volume: 29, Issue:6 Topics: Absorptiometry, Photon; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic; Zoledronic Acid	2017
Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer. Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:12 Topics: Alpha Particles; Animals; Bone Neoplasms; Clinical Trials, Phase III as Topic; Disease Progression; Humans; Neoplasms; Quality of Life; Radiopharmaceuticals; Radium; Survival Rate	2009
[Encounter of cancer cells with bone. Management of bone metastasis arising from prostate cancer]. Clinical calcium, 2011, Volume: 21, Issue:3 Topics: Antibodies, Monoclonal; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Evidence-Based Medicine; Humans; Imidazoles; Male; Molecular Targeted Therapy; NF-kappa B; Prostatic Neoplasms; Radioisotopes; Radium; Receptor Activator of Nuclear Factor-kappa B; Strontium; Zoledronic Acid	2011
Clinical dosimetry in the treatment of bone tumors: old and new agents. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:2 Topics: Bone Neoplasms; Humans; Pain; Palliative Care; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radium; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes	2011
Novel molecular targets for the therapy of castration-resistant prostate cancer. European urology, 2012, Volume: 61, Issue:5 Topics: Abiraterone Acetate; Androstadienes; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Neoplasms; Cancer Vaccines; Carcinoma; Clinical Trials, Phase III as Topic; Clusterin; Dasatinib; Denosumab; Humans; Ipilimumab; Male; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Pyridines; Pyrimidines; Quinolines; Quinolones; Radium; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Thiazoles; Tissue Extracts; Treatment Outcome; Vaccines, Synthetic	2012
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Humans; Male; Pain; Palliative Care; Prostatic Neoplasms; Radium; Survival Analysis	2012
Progress in the treatment of bone metastases in cancer patients. Expert opinion on investigational drugs, 2012, Volume: 21, Issue:6 Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Humans; Male; Prostatic Neoplasms; Quality of Life; Radium; Survival Rate	2012
Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection. Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
Use of radionuclides in metastatic prostate cancer: pain relief and beyond. Current opinion in supportive and palliative care, 2012, Volume: 6, Issue:3 Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium	2012
Radium in the environment: exposure pathways and health effects. Reviews on environmental health, 2012, Volume: 27, Issue:1 Topics: Bone Neoplasms; Environmental Exposure; Environmental Pollutants; Humans; Leukemia; Neoplasms; Occupational Exposure; Radiation Dosage; Radioactive Pollutants; Radium; Risk Factors	2012
[Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:33 Topics: Bone Density Conservation Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Diphosphonates; Germany; Guideline Adherence; Humans; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radioisotopes; Radium; Spinal Cord Compression; Spinal Neoplasms; Strontium; Survival Rate; Urologic Neoplasms	2012
New and emerging therapies for bone metastases in genitourinary cancers. European urology, 2013, Volume: 63, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; RANK Ligand; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urothelium; Zoledronic Acid	2013
Radium-223 for the treatment of prostate cancer. Expert opinion on investigational drugs, 2013, Volume: 22, Issue:3 Topics: Bone Neoplasms; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Radium	2013
Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation. International journal of radiation biology, 2003, Volume: 79, Issue:1 Topics: Animals; Bone Neoplasms; Humans; Leukemia, Radiation-Induced; Liver Neoplasms; Lung Neoplasms; Neoplasms, Radiation-Induced; Plutonium; Radium; Radon; Thorium Dioxide	2003
Target cells in internal dosimetry. Radiation protection dosimetry, 2003, Volume: 105, Issue:1-4 Topics: Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Organ Specificity; Osteosarcoma; Radiation Dosage; Radioactive Pollutants; Radiometry; Radium	2003
High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities? Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Oct-15, Volume: 12, Issue:20 Pt 2 Topics: Alpha Particles; Animals; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Prostatic Neoplasms; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radiotherapy, Adjuvant; Radium; Randomized Controlled Trials as Topic	2006
Pathology of radium-induced bone tumors: new aspects of histopathology and histogenesis. Radiation research, 1999, Volume: 152, Issue:6 Suppl Topics: Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Radium; Sarcoma	1999
Review of 239Pu and 226Ra effects in beagles. Health physics, 2001, Volume: 81, Issue:6 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Female; Fractures, Bone; Male; Neoplasms, Radiation-Induced; Plutonium; Radiation Injuries; Radium; Soft Tissue Injuries	2001
Radiation-induced sarcomas of bone. Skeletal radiology, 1979, Jun-06, Volume: 4, Issue:2 Topics: Animals; Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Radium; Risk; Sarcoma; Spondylitis, Ankylosing	1979
Hazards of plutonium with special reference to the skeleton. Nature, 1976, Feb-19, Volume: 259, Issue:5544 Topics: Animals; Body Burden; Bone and Bones; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Leukemia, Myeloid; Maximum Allowable Concentration; Models, Biological; Osteosarcoma; Plutonium; Radiation Effects; Radium	1976
Bone tumor induction after incorporation of short-lived radionuclides. Radiation and environmental biophysics, 1991, Volume: 30, Issue:3 Topics: Animals; Bone Neoplasms; Lutetium; Mice; Neoplasms, Radiation-Induced; Radium; Thorium	1991
1987 Douglas Lea memorial lecture. Particle dosimetry in bone and the toxicity of bone-seeking radionuclides. Physics in medicine and biology, 1988, Volume: 33, Issue:4 Topics: Bone and Bones; Bone Neoplasms; Densitometry; Female; Humans; Leukemia, Radiation-Induced; Male; Neoplasms, Radiation-Induced; Occupational Diseases; Radiation Dosage; Radioisotopes; Radionuclide Imaging; Radium; Strontium	1988
[The combined action of ionizing radiation and carcinogens]. Voprosy onkologii, 1969, Volume: 15, Issue:3 Topics: Animals; Benz(a)Anthracenes; Bone Neoplasms; Carbon Tetrachloride Poisoning; Carcinogens; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Cobalt Isotopes; Fibrosarcoma; Fluorenes; Gold Isotopes; Guinea Pigs; Liver Neoplasms; Methylcholanthrene; Methylthiouracil; Mice; Neoplasms, Radiation-Induced; Nitrosamines; Osteosarcoma; p-Dimethylaminoazobenzene; Papilloma; Phosphorus Isotopes; Precancerous Conditions; Radiation Injuries, Experimental; Radium; Sarcoma, Experimental; Time Factors; Urethane; Yttrium Isotopes	1969
Late neoplastic changes following medical irradiation. Radiology, 1972, Volume: 105, Issue:3 Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Chromosomes; Cranial Sinuses; Female; Fetus; Fluoroscopy; Gastrointestinal Neoplasms; Humans; Leukemia, Radiation-Induced; Liver Neoplasms; Male; Mastitis; Neoplasms, Radiation-Induced; Pregnancy; Radiation Genetics; Radiotherapy; Radiotherapy Dosage; Radium; Thorium Dioxide; Time Factors; Uterine Hemorrhage; Uterine Neoplasms	1972
Cancer induction in man from internal radioactivity. Health physics, 1973, Volume: 25, Issue:6 Topics: Bone Neoplasms; Contrast Media; Germany; Humans; Iodine Radioisotopes; Leukemia, Radiation-Induced; Liver Neoplasms; Lung Neoplasms; Mining; Neoplasms, Radiation-Induced; Pacific Islands; Paranasal Sinus Neoplasms; Phosphorus Radioisotopes; Polycythemia Vera; Radioactive Fallout; Radiotherapy; Radium; Radon; Spondylitis, Ankylosing; Thorium; Thorium Dioxide; Thyroid Neoplasms; United States; Uranium	1973

Trials

50 trial(s) available for radium and Bone Neoplasms

Article	Year
Current problems in cancer, 2021, Volume: 45, Issue:5 Topics: Adolescent; Adult; Bone Neoplasms; Female; Fluorine Radioisotopes; Humans; Lung Neoplasms; Neoplasm Metastasis; Osteoblastoma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radioisotopes; Radium; Sodium Fluoride	2021
A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases. BMC cancer, 2022, Apr-15, Volume: 22, Issue:1 Topics: Bone Neoplasms; Cancer Pain; Humans; Male; Pentetic Acid; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium	2022
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial. European journal of cancer (Oxford, England : 1990), 2022, Volume: 173 Topics: Abiraterone Acetate; Androgen Antagonists; Benzamides; Bone Neoplasms; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Receptors, Androgen	2022
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response. JNCI cancer spectrum, 2023, Oct-31, Volume: 7, Issue:6 Topics: Bone Neoplasms; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2023
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases. The Prostate, 2019, Volume: 79, Issue:14 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Disease Progression; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate	2019
A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study. International journal of clinical oncology, 2020, Volume: 25, Issue:4 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Disease-Free Survival; Double-Blind Method; Fractures, Bone; Humans; Male; Middle Aged; Placebos; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome	2020
Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer. Cancer medicine, 2020, Volume: 9, Issue:3 Topics: Adult; Aged; Alpha Particles; Antineoplastic Agents, Hormonal; Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Chemoradiotherapy; Denosumab; Female; Fulvestrant; Humans; Injections, Intravenous; Middle Aged; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radioisotopes; Radium; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	2020
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 05-01, Volume: 26, Issue:9 Topics: Aged; Aged, 80 and over; Androgen Receptor Antagonists; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Chemoradiotherapy; Collagen Type I; Humans; Male; Middle Aged; Nitriles; Peptides; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Rate	2020
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial. Trials, 2020, Jan-15, Volume: 21, Issue:1 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Capecitabine; Case-Control Studies; Disease-Free Survival; Female; Humans; Neoplasm Metastasis; Radioisotopes; Radium; Safety; Treatment Outcome	2020
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2020, Volume: 31, Issue:2 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS). BMC cancer, 2020, Jun-01, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Male; Middle Aged; Progression-Free Survival; Prostatic Neoplasms; Radioisotopes; Radiosurgery; Radium; Randomized Controlled Trials as Topic; Young Adult	2020
Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study. Asia-Pacific journal of clinical oncology, 2021, Volume: 17, Issue:6 Topics: Bone Neoplasms; Humans; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2021
Fracture Risk in Men with Metastatic Prostate Cancer Treated With Radium-223. Clinical genitourinary cancer, 2021, Volume: 19, Issue:5 Topics: Bone Neoplasms; Fractures, Bone; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Whole Body Imaging	2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. PloS one, 2021, Volume: 16, Issue:6 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Nitriles; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate	2021
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases. International journal of clinical oncology, 2017, Volume: 22, Issue:5 Topics: Aged; Alkaline Phosphatase; Anemia; Asian People; Bone Neoplasms; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Thrombocytopenia; Treatment Outcome	2017
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer. International journal of clinical oncology, 2018, Volume: 23, Issue:1 Topics: Aged; Alkaline Phosphatase; Antineoplastic Agents; Bone Neoplasms; Humans; Lymphocyte Count; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2018
Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Oct-01, Volume: 28, Issue:10 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Neoplasms; Humans; Kallikreins; Male; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Re-Irradiation	2017
Radium-223 international early access program: results from the Spanish subset. Future oncology (London, England), 2018, Volume: 14, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Disease-Free Survival; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Spain	2018
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:5 Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Paclitaxel; Radium; Safety	2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. BMC cancer, 2019, Jan-07, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Androstenes; Bone Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2019
Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-01, Volume: 25, Issue:13 Topics: Adolescent; Adult; Aged; Alpha Particles; Bone Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radioisotopes; Radium; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome; Young Adult	2019
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology, 2019, Volume: 20, Issue:3 Topics: Abiraterone Acetate; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Fractures, Bone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prednisolone; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases. International journal of clinical oncology, 2019, Volume: 24, Issue:5 Topics: Administration, Intravenous; Aged; Anemia; Bone Neoplasms; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radiation Injuries; Radioisotopes; Radium	2019
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial. European journal of cancer (Oxford, England : 1990), 2019, Volume: 114 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer. PloS one, 2019, Volume: 14, Issue:5 Topics: Aged; Alkaline Phosphatase; Biomarkers, Tumor; Biopsy; Bone and Bones; Bone Neoplasms; Cadherins; Core Binding Factor Alpha 1 Subunit; Disease Progression; Gene Expression; Humans; Male; Molecular Targeted Therapy; Neoplastic Cells, Circulating; Osteonectin; Osteopontin; Prostate; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Analysis; Tumor Microenvironment	2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program. Clinical genitourinary cancer, 2019, Volume: 17, Issue:5 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Rate; Treatment Outcome	2019
Compartmental Model for International journal of radiation oncology, biology, physics, 2019, 11-15, Volume: 105, Issue:4 Topics: Alpha Particles; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Humans; Intestine, Large; Intestine, Small; Male; Models, Biological; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2019
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Dose-Response Relationship, Radiation; Endpoint Determination; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Tissue Distribution	2013
Alpha emitter radium-223 and survival in metastatic prostate cancer. The New England journal of medicine, 2013, Jul-18, Volume: 369, Issue:3 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Double-Blind Method; Humans; Isotopes; Kaplan-Meier Estimate; Male; Middle Aged; Prostatic Neoplasms; Radium	2013
Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-01, Volume: 20, Issue:1 Topics: Aged; Animals; Bone Neoplasms; Double-Blind Method; Drug Approval; Humans; Kaplan-Meier Estimate; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome; United States; United States Food and Drug Administration	2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancer. Health physics, 2014, Volume: 106, Issue:4 Topics: Aged; Aged, 80 and over; Alpha Particles; Antineoplastic Agents; Body Weight; Bone and Bones; Bone Neoplasms; Chlorides; Dose-Response Relationship, Radiation; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant; Radiation Protection; Radioisotopes; Radiopharmaceuticals; Radium; Time Factors; Treatment Outcome	2014
A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast cancer research and treatment, 2014, Volume: 145, Issue:2 Topics: Aged; Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Collagen Type I; Female; Humans; Middle Aged; Peptides; Radioisotopes; Radium; Treatment Outcome	2014
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. The Lancet. Oncology, 2014, Volume: 15, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium	2014
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPC The Lancet. Oncology, 2014, Volume: 15, Issue:12 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Double-Blind Method; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Taxoids	2014
Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety. Expert opinion on drug safety, 2015, Volume: 14, Issue:7 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Bone Neoplasms; Bone Remodeling; Collagen Type I; Docetaxel; Drug Monitoring; Humans; Male; Middle Aged; Neoplasm Staging; Peptides; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Analysis; Taxoids; Treatment Outcome	2015
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:9 Topics: Aged; Body Burden; Bone Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Radium; Tissue Distribution; Treatment Outcome; Whole-Body Counting	2015
Haematopoietic toxicity of radium-223 in patients with high skeletal tumour burden. Nuklearmedizin. Nuclear medicine, 2015, Volume: 54, Issue:5 Topics: Bone Marrow Diseases; Bone Neoplasms; Female; Humans; Male; Radiation Injuries; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Treatment Outcome	2015
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:5 Topics: Aged; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Double-Blind Method; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Standard of Care; Taxoids; Treatment Outcome	2016
Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. The Prostate, 2016, Volume: 76, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Double-Blind Method; Humans; Male; Middle Aged; Placebos; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate; Taxoids; Treatment Outcome	2016
Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases. Annals of nuclear medicine, 2016, Volume: 30, Issue:7 Topics: Aged; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radioisotopes; Radiometry; Radiotherapy Dosage; Radium; Tissue Distribution	2016
Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial. European urology, 2016, Volume: 70, Issue:5 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Double-Blind Method; Drug Monitoring; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Analysis; Symptom Assessment; Treatment Outcome	2016
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial. The Lancet. Oncology, 2016, Volume: 17, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Neoplasm Grading; Neoplasm Staging; Prognosis; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Survival Rate	2016
Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Double-Blind Method; Humans; Incidence; Male; Middle Aged; Neutropenia; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Risk Factors; Thrombocytopenia	2017
Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial. European journal of cancer (Oxford, England : 1990), 2017, Volume: 71 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Double-Blind Method; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium	2017
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990), 2012, Volume: 48, Issue:5 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Humans; Male; Pain; Palliative Care; Prostatic Neoplasms; Radium; Survival Analysis	2012
A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer. European urology, 2013, Volume: 63, Issue:2 Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Alpha Particles; Bone Neoplasms; Dose-Response Relationship, Radiation; Double-Blind Method; Drug Administration Schedule; Humans; Kallikreins; Male; Middle Aged; Pain Measurement; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome	2013
Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature review. BMJ case reports, 2012, Nov-01, Volume: 2012 Topics: Adenocarcinoma; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Drug Resistance, Neoplasm; Humans; Male; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2012
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-15, Volume: 11, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Alpha Particles; Bone Neoplasms; Breast Neoplasms; Diarrhea; Dose-Response Relationship, Radiation; Fatigue; Female; Follow-Up Studies; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Neutropenia; Pain; Prostatic Neoplasms; Radionuclide Imaging; Radium; Treatment Outcome; Vomiting	2005
[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2006, Volume: 50, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Treatment Outcome	2006
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study. The Lancet. Oncology, 2007, Volume: 8, Issue:7 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Placebos; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radium; Survival Rate	2007

Other Studies

323 other study(ies) available for radium and Bone Neoplasms

Article	Year
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC. Future oncology (London, England), 2022, Volume: 18, Issue:1 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Benzamides; Bone Neoplasms; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2022
[Exploratory Analysis Results from Post-marketing Surveillance Study of Radium-223 in Japanese Patients with Castration-resistant Prostate Cancer and Bone Metastases: Subgroup Analysis by Age]. Kaku igaku. The Japanese journal of nuclear medicine, 2021, Volume: 58, Issue:1 Topics: Aged; Bone Neoplasms; Humans; Japan; Laboratories, Clinical; Male; Product Surveillance, Postmarketing; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2021
A qualitative research study in Japan investigating patients' experience with metastatic castration-resistant prostate cancer: from diagnosis to decision for Ra-223 treatment. Future oncology (London, England), 2021, Volume: 17, Issue:36 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cost of Illness; Decision Making; Humans; Interviews as Topic; Japan; Male; Middle Aged; Physicians; Prostatic Neoplasms, Castration-Resistant; Qualitative Research; Quality of Life; Radium	2021
Graphene Quantum Dots for Molecular Radiotherapy: Radiolabeled Graphene Quantum Dots with Radium ( Journal of biomedical nanotechnology, 2021, Sep-01, Volume: 17, Issue:9 Topics: Bone Neoplasms; Graphite; Humans; Osteosarcoma; Quantum Dots; Radium	2021
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure. International journal of radiation biology, 2022, Volume: 98, Issue:5 Topics: Bone Neoplasms; Gene Expression; Humans; Male; MicroRNAs; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; RNA, Messenger	2022
Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer. Health physics, 2022, 03-01, Volume: 122, Issue:3 Topics: Bone Neoplasms; Dialysis Solutions; Humans; Male; Peritoneal Dialysis; Prostatic Neoplasms, Castration-Resistant; Radium	2022
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer. Anticancer research, 2022, Volume: 42, Issue:2 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Chemoradiotherapy; Ethinyl Estradiol; Humans; Japan; Kallikreins; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Analysis; Treatment Outcome	2022
Radium-223 for metastatic, castration-resistant prostate cancer: A retrospective chart review study of real-world use in a tertiary hospital in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:10 Topics: Alkaline Phosphatase; Bone Neoplasms; Humans; Male; Pain; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Retrospective Studies; Taiwan; Tertiary Care Centers; Treatment Outcome	2022
Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study). Prostate cancer and prostatic diseases, 2022, Volume: 25, Issue:2 Topics: Aged; Bone Neoplasms; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retrospective Studies; Treatment Outcome	2022
[ Drug delivery, 2022, Volume: 29, Issue:1 Topics: Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Humans; Micelles; Nanoparticles; Osteosarcoma; Particle Size; Poloxamer; Radioisotopes; Radiopharmaceuticals; Radium	2022
Radium-223 in the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Irish medical journal, 2022, 02-17, Volume: 115, Issue:2 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2022
Ocular complications with the use of radium-223: a case series. Radiation oncology (London, England), 2022, May-17, Volume: 17, Issue:1 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radium	2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate, 2022, Volume: 82, Issue:12 Topics: Bone Neoplasms; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2022
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy. Prostate cancer and prostatic diseases, 2023, Volume: 26, Issue:1 Topics: Alkaline Phosphatase; Analgesics, Opioid; Bone Neoplasms; Hemoglobins; Humans; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Psychological Distress; Quality of Life; Radium	2023
Administration of radium-223 and the prognosis in Japanese bone metastatic castration-resistant prostate cancer patients: A large database study. International journal of urology : official journal of the Japanese Urological Association, 2022, Volume: 29, Issue:9 Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Male; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2022
S-values for radium-223 and absorbed doses estimates for Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2022, Volume: 189 Topics: Bismuth; Body Weight; Bone Neoplasms; Female; Humans; Male; Monte Carlo Method; Phantoms, Imaging; Polonium; Radioisotopes; Radium; Radon; Thallium	2022
[Retrospective practice-related care research study on therapy of mCPRC with radium-223 dichloride]. Aktuelle Urologie, 2022, Volume: 53, Issue:6 Topics: Bone Neoplasms; Fractures, Bone; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2022
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden. Clinical genitourinary cancer, 2023, Volume: 21, Issue:1 Topics: Bone Neoplasms; Fractures, Bone; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Sweden	2023
Efficacy and Safety of Radium-223 for Castration-resistant Prostate Cancer With Bone Metastasis Before and After Docetaxel. Anticancer research, 2022, Volume: 42, Issue:10 Topics: Bone Neoplasms; Docetaxel; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2022
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study. International journal of urology : official journal of the Japanese Urological Association, 2023, Volume: 30, Issue:2 Topics: Anemia; Bone Neoplasms; Female; Humans; Male; Pain; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2023
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) T European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:5 Topics: Bone Neoplasms; East Asian People; Humans; Male; Nomograms; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2023
Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical Parameters. The oncologist, 2023, 03-17, Volume: 28, Issue:3 Topics: Bone and Bones; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2023
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases. The Prostate, 2023, Volume: 83, Issue:6 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2023
Nano-hydroxyapatite radiolabeled with radium dichloride [ Colloids and surfaces. B, Biointerfaces, 2023, Volume: 223 Topics: Bone Neoplasms; Humans; Nanostructures; Osteosarcoma; Radiopharmaceuticals; Radium	2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model. International journal of molecular sciences, 2023, Jan-22, Volume: 24, Issue:3 Topics: Benzamides; Bone Neoplasms; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium	2023
Sarcopenia in Men With Bone-Predominant Metastatic Castration-Resistant Prostate Cancer Undergoing Ra-223 Therapy. Clinical genitourinary cancer, 2023, Volume: 21, Issue:4 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Sarcopenia	2023
Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study. Anticancer research, 2023, Volume: 43, Issue:4 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2023
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment. International journal of urology : official journal of the Japanese Urological Association, 2023, Volume: 30, Issue:11 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2023
Editorial Comment to Bone-modifying agents are protective for symptomatic skeletal events in radium-223 treatment. International journal of urology : official journal of the Japanese Urological Association, 2023, Volume: 30, Issue:11 Topics: Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2023
Radium-223 and bone metastatic disease: still more to learn. JNCI cancer spectrum, 2023, Oct-31, Volume: 7, Issue:6 Topics: Bone Neoplasms; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2023
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial. International journal of clinical oncology, 2019, Volume: 24, Issue:12 Topics: Abiraterone Acetate; Bone Density; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Radioisotope Therapy of Bone Metastases-A Nuclear Medicine Perspective. Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1 Topics: Bone Neoplasms; Humans; Nuclear Medicine; Radiopharmaceuticals; Radium	2019
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? Urologic oncology, 2019, Volume: 37, Issue:12 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy, Adjuvant; Disease Progression; Follow-Up Studies; Humans; Male; Neoplasm Grading; Prognosis; Prostate; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Survival Analysis; Treatment Outcome	2019
Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment. Radiology and oncology, 2019, 12-19, Volume: 54, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Software; Survival Analysis	2019
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population. International journal of cancer, 2020, 08-15, Volume: 147, Issue:4 Topics: Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Benzamides; Bone Neoplasms; Chemoradiotherapy; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Phenylthiohydantoin; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radium; Registries; Taxoids	2020
Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience. Nuclear medicine communications, 2020, Volume: 41, Issue:4 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2020
The Relationship Between Total Lesion Activity on Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:6 Topics: Aged; Aged, 80 and over; Alpha Particles; Bone and Bones; Bone Neoplasms; Choline; Feasibility Studies; Fluorine Radioisotopes; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retrospective Studies; Treatment Outcome	2020
Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223. Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:7 Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Humans; Male; Mice; Models, Animal; Phantoms, Imaging; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	2020
Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice. Endocrine, 2020, Volume: 69, Issue:1 Topics: Androgen Antagonists; Bone Neoplasms; Humans; Longitudinal Studies; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2020
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:11 Topics: Abiraterone Acetate; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2020
Clinical aspects of mCRPC management in patients treated with radium-223. Scientific reports, 2020, 04-21, Volume: 10, Issue:1 Topics: Aged; Alkaline Phosphatase; Anemia; Bone Neoplasms; Cohort Studies; Hemoglobins; Humans; Kaplan-Meier Estimate; Male; Pain; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium	2020
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223. Aging clinical and experimental research, 2021, Volume: 33, Issue:3 Topics: Aged; Bone Neoplasms; Humans; Italy; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2021
In situ Generated Current radiopharmaceuticals, 2020, Volume: 13, Issue:2 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Humans; Lead Radioisotopes; Ligands; Male; Mice; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Thorium	2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases, 2020, Volume: 23, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Zoledronic Acid	2020
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer. Future oncology (London, England), 2020, Volume: 16, Issue:19 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Databases, Factual; Drug Administration Schedule; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retrospective Studies; Survival Rate; Treatment Outcome	2020
ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223. American journal of clinical oncology, 2020, Volume: 43, Issue:8 Topics: Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Humans; Radioisotopes; Radium	2020
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223. BMC cancer, 2020, Jun-29, Volume: 20, Issue:1 Topics: Animals; Bone Neoplasms; Brachytherapy; Cell Line, Tumor; Computer Simulation; Disease Progression; Humans; Intravital Microscopy; Male; Mice; Microscopy, Fluorescence; Models, Biological; Prostatic Neoplasms; Radiation Tolerance; Radium; Tibia; Xenograft Model Antitumor Assays	2020
Typical Acute Traumatic Fracture Healing in an 83-Year-Old Man Undergoing 223Ra Treatment for Prostatic Cancer Bone Metastases. Clinical nuclear medicine, 2020, Volume: 45, Issue:9 Topics: Aged, 80 and over; Bone Neoplasms; Fracture Healing; Humans; Male; Prostatic Neoplasms; Radium; Tibial Fractures	2020
Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223. Cancer reports (Hoboken, N.J.), 2019, Volume: 2, Issue:5 Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Feasibility Studies; Humans; Image Interpretation, Computer-Assisted; Japan; Kallikreins; Kaplan-Meier Estimate; Male; Middle Aged; Neural Networks, Computer; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Radium; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed; Tumor Burden	2019
Radium-223 in mCPRC patients: a large real-life Italian multicenter study. Minerva urology and nephrology, 2022, Volume: 74, Issue:1 Topics: Bone Neoplasms; Humans; Italy; Quality of Life; Radium; Treatment Outcome	2022
Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center. Prostate cancer and prostatic diseases, 2021, Volume: 24, Issue:1 Topics: Aged; Bone Neoplasms; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome; United States	2021
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases. International journal of clinical oncology, 2021, Volume: 26, Issue:1 Topics: Aged; Bone Neoplasms; Humans; Male; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2021
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy. Medicine, 2020, Sep-18, Volume: 99, Issue:38 Topics: Aged; Bone Neoplasms; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radium; Retrospective Studies; Surveys and Questionnaires	2020
Dynamic changes of bone metastasis predict bone-predominant status to benefit from radium-223 dichloride for patients with castration-resistant prostate cancer. Cancer medicine, 2020, Volume: 9, Issue:22 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Clinical Decision-Making; Humans; Male; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors	2020
Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2020, Oct-01, Volume: 92, Issue:3 Topics: Aged; Bone Neoplasms; Cancer Pain; Humans; Male; Palliative Care; Prostatic Neoplasms, Castration-Resistant; Radium; Retreatment	2020
Comment on: 'Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer' by De Vincentis et al. European journal of cancer (Oxford, England : 1990), 2021, Volume: 144 Topics: Bone Neoplasms; DNA Damage; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2021
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients. Future oncology (London, England), 2021, Volume: 17, Issue:7 Topics: Aged; Aged, 80 and over; Androgen Receptor Antagonists; Bone Neoplasms; Chemoradiotherapy; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Neoplasm Grading; Patient Selection; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Retrospective Studies; Survival Analysis; Treatment Outcome	2021
Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status International journal of clinical oncology, 2021, Volume: 26, Issue:4 Topics: Androgens; Bone Neoplasms; Humans; Japan; Male; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome	2021
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:10 Topics: Alkaline Phosphatase; Biomarkers; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome	2021
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world population. The Prostate, 2021, Volume: 81, Issue:7 Topics: Aged; Androstenes; Benzamides; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Rate; Veterans	2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 06-01, Volume: 27, Issue:11 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Exosomes; Extracellular Vesicles; Gene Expression; Gene Expression Profiling; Humans; Immune Checkpoint Proteins; Male; Mice; Prostatic Neoplasms; Radiopharmaceuticals; Radium; RNA; Survival Rate; Tumor Microenvironment	2021
Kinetics of radium-223 and its effects on survival, proliferation and DNA damage in lymph-node and bone metastatic prostate cancer cell lines. International journal of radiation biology, 2021, Volume: 97, Issue:5 Topics: Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage; Humans; Kinetics; Lymphatic Metastasis; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without Cancer biotherapy & radiopharmaceuticals, 2021, Volume: 36, Issue:5 Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Retrospective Studies; Survival Rate; Taxoids	2021
Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings. The Prostate, 2021, Volume: 81, Issue:10 Topics: Academic Medical Centers; Aged; Aged, 80 and over; Bone Neoplasms; Community Health Services; Disease Management; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate; Treatment Outcome	2021
Radium Ra 223 Alpha Therapy for Prostate Cancer Bone Metastasis. Radiologic technology, 2021, Volume: 92, Issue:6 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2021
Extraction of Nuklearmedizin. Nuclear medicine, 2017, Jun-13, Volume: 56, Issue:3 Topics: Blood Component Removal; Bone Neoplasms; Dialysis Solutions; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radiation Protection; Radioisotopes; Radiopharmaceuticals; Radium; Renal Dialysis; Treatment Outcome	2017
Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy. Oncotarget, 2017, Jul-04, Volume: 8, Issue:27 Topics: Aged; Biomarkers; Blood Cell Count; Bone Neoplasms; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Off-Label Use; Prostatectomy; Prostatic Neoplasms; Radioisotopes; Radium; Single Photon Emission Computed Tomography Computed Tomography	2017
223Ra-dichloride response in a patient with Paget disease and bone metastases secondary to castration-resistant prostate cancer. Tumori, 2017, Nov-15, Volume: 103, Issue:Suppl. 1 Topics: Aged; Bone Neoplasms; Humans; Male; Osteitis Deformans; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium	2017
Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed? Clinical nuclear medicine, 2017, Volume: 42, Issue:10 Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome	2017
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:4 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Hematologic Tests; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Tumor Burden	2018
Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2017, Volume: 15, Issue:9 Topics: Bone Neoplasms; Clinical Decision-Making; Combined Modality Therapy; Disease Progression; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Patient Selection; Prostatic Neoplasms, Castration-Resistant; Radium; Symptom Assessment; Treatment Outcome	2017
On the European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:2 Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Positron-Emission Tomography; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed	2018
Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer. Clinical genitourinary cancer, 2018, Volume: 16, Issue:2 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bone Neoplasms; CD8-Positive T-Lymphocytes; Humans; Interferon-gamma; Interleukin-13; Male; Middle Aged; Prednisone; Programmed Cell Death 1 Receptor; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome; Tumor Necrosis Factor-alpha	2018
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily Practice. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies	2018
High-Energy Collimator Is Preferable to Medium-Energy Collimator for Evaluating 223Ra Uptake in Bone Metastasis at 2 Weeks Postinjection. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Topics: Aged, 80 and over; Biological Transport; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Radium	2018
Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223. Clinical genitourinary cancer, 2018, Volume: 16, Issue:2 Topics: Aged; Antigens, Surface; Bone Neoplasms; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium; Survival Analysis; Treatment Outcome	2018
Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer. Nuclear medicine communications, 2018, Volume: 39, Issue:2 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Whole-Body Counting	2018
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:5 Topics: Bone Neoplasms; Europe; Humans; Male; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2018
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience. Oncology, 2018, Volume: 94, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Humans; Italy; Male; Middle Aged; Prednisone; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Retrospective Studies; Taxoids	2018
Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Annals of nuclear medicine, 2018, Volume: 32, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone and Bones; Bone Neoplasms; Humans; Male; Middle Aged; Prostatic Neoplasms; Radium; Tumor Burden	2018
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with Annals of nuclear medicine, 2018, Volume: 32, Issue:2 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; ROC Curve; Survival Analysis	2018
DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223. Clinical genitourinary cancer, 2018, Volume: 16, Issue:2 Topics: Aged; Biomarkers, Tumor; Bone Neoplasms; DNA Repair; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Sequence Analysis, DNA; Treatment Outcome	2018
Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:5 Topics: Bone Neoplasms; Humans; Nuclear Medicine; Oncologists; Radioisotopes; Radionuclide Imaging; Radium	2018
The Pseudo-Pelger huët Cell as a Retrospective Dosimeter: Analysis of a Radium Dial Painter Cohort. Health physics, 2019, Volume: 117, Issue:2 Topics: Adolescent; Adult; Biological Assay; Bone Neoplasms; Female; Humans; Male; Mastoid; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Pelger-Huet Anomaly; Radiation Exposure; Radiation Injuries; Radiation Monitoring; Radium; Retrospective Studies; Young Adult	2019
Fatal Intracranial Hemorrhage Due to Thrombocytopenia in a Patient With Castration-Resistant Prostate Cancer Showing Extensive Bone Uptake of Injected 223Ra Dichloride. Clinical nuclear medicine, 2018, Volume: 43, Issue:7 Topics: Bone Neoplasms; Humans; Intracranial Hemorrhages; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Thrombocytopenia; Tomography, Emission-Computed, Single-Photon	2018
Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223? Clinical genitourinary cancer, 2018, Volume: 16, Issue:5 Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Denosumab; Docetaxel; Humans; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Radium; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2018
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study. Nuclear medicine communications, 2018, Volume: 39, Issue:7 Topics: Aged; Aged, 80 and over; Blood; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium	2018
Osteonecrosis of the Jaw in a Patient With Bone Metastatic Prostate Cancer After Long-term Bisphosphonate Treatment With Severe Deterioration Following Radium-223. Clinical genitourinary cancer, 2018, Volume: 16, Issue:5 Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Neoplasms; Diphosphonates; Disease Progression; Fatal Outcome; Humans; Male; Prostatic Neoplasms; Radium	2018
Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 2018, Volume: 30, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Neoplasms; Health Status; Hemoglobins; Humans; Lymphocyte Count; Male; Middle Aged; Neutrophils; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Survival Rate	2018
Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide. Experimental oncology, 2018, Volume: 40, Issue:2 Topics: Abiraterone Acetate; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Radium; Tomography, X-Ray Computed; Treatment Outcome	2018
Final Outcome of 223Ra-therapy and the Role of 18F-fluoride-PET in Response Evaluation in Metastatic Castration-resistant Prostate Cancer-A Single Institution Experience. Current radiopharmaceuticals, 2018, Volume: 11, Issue:2 Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium	2018
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy. BMJ case reports, 2018, Jul-06, Volume: 2018 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Calcium Carbonate; Ergocalciferols; Humans; Hypocalcemia; Male; Middle Aged; Prostatic Neoplasms; Radioisotopes; Radium; Whole Body Imaging	2018
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer. Clinical genitourinary cancer, 2018, Volume: 16, Issue:6 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cell Count; Disease Progression; Follow-Up Studies; Humans; Injections, Intravenous; Male; Neoplastic Cells, Circulating; Prognosis; Progression-Free Survival; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiotherapy Dosage; Radium	2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects. European urology, 2019, Volume: 76, Issue:2 Topics: Aged; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Germ-Line Mutation; Humans; Male; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Recombinational DNA Repair; Survival Analysis; Treatment Outcome	2019
[Radium 223 in castration resistant prostate cancer.] Archivos espanoles de urologia, 2018, Volume: 71, Issue:8 Topics: Antineoplastic Agents; Bone Neoplasms; Forecasting; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2018
Impact of timing of administration of bone supportive therapy on pain palliation from radium-223. Cancer treatment and research communications, 2019, Volume: 18 Topics: Androstenes; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chemoradiotherapy; Follow-Up Studies; Humans; Male; Nitriles; Pain Management; Palliative Care; Phenylthiohydantoin; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Time Factors	2019
Mechanistic Modeling of Radium-223 Treatment of Bone Metastases. International journal of radiation oncology, biology, physics, 2019, 04-01, Volume: 103, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Kaplan-Meier Estimate; Models, Biological; Radioisotopes; Radium; Time Factors; Tumor Burden	2019
Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone. Journal of the National Cancer Institute, 2019, 10-01, Volume: 111, Issue:10 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Radiation; Humans; Male; Mice; Microscopy, Fluorescence, Multiphoton; Prostatic Neoplasms; Radium; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro. Biomaterials, 2019, Volume: 197 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Culture Techniques; Cell Proliferation; Docetaxel; Drug Screening Assays, Antitumor; Humans; Male; Mice, SCID; PC-3 Cells; Prostatic Neoplasms; Radium; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment	2019
Assessment of the radiation absorbed dose produced by Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2019, Volume: 146 Topics: Actinium; Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Models, Biological; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Tumor Microenvironment	2019
Updated: Tumori, 2019, Volume: 105, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2019
Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response. Nuclear medicine communications, 2019, Volume: 40, Issue:6 Topics: Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium; Retrospective Studies; Treatment Outcome	2019
Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases. Clinical genitourinary cancer, 2019, Volume: 17, Issue:3 Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome; Zoledronic Acid	2019
Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer. The Prostate, 2019, Volume: 79, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Disease Progression; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Soft Tissue Neoplasms; Treatment Outcome	2019
Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital. Anticancer research, 2019, Volume: 39, Issue:5 Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome	2019
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium. European journal of cancer care, 2019, Volume: 28, Issue:5 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cancer Pain; Humans; Male; Middle Aged; Pain Measurement; Prostatic Neoplasms, Castration-Resistant; Psychological Distress; Quality of Life; Radium; Retrospective Studies	2019
Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial. European urology, 2019, Volume: 76, Issue:5 Topics: Abiraterone Acetate; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium	2019
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis. Journal of the National Cancer Institute, 2013, Jun-19, Volume: 105, Issue:12 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cachexia; Cell Proliferation; Diphosphonates; Disease Models, Animal; DNA Breaks, Double-Stranded; DNA, Neoplasm; Doxorubicin; Female; Imidazoles; Kaplan-Meier Estimate; Mice; Osteoblasts; Osteoclasts; Radioisotopes; Radium; Stem Cells; Tumor Cells, Cultured; Zoledronic Acid	2013
FDA approves radiopharmaceutical for metastatic prostate cancer. Cancer discovery, 2013, Volume: 3, Issue:7 Topics: Bone Neoplasms; Clinical Trials as Topic; Drug Approval; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; United States; United States Food and Drug Administration	2013
Fighting prostate cancer with radium-223--not your Madame's isotope. The New England journal of medicine, 2013, Jul-18, Volume: 369, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical. Clinical nuclear medicine, 2013, Volume: 38, Issue:9 Topics: Aged; Bone Neoplasms; Drug Approval; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2013
Radium Ra 223 dichloride in castration-resistant prostate cancer. Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49, Issue:8 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate	2013
Radium - 223 (Xofigo) for prostate cancer. The Medical letter on drugs and therapeutics, 2013, Sep-30, Volume: 55, Issue:1426 Topics: Antineoplastic Agents; Bone Neoplasms; Drug Approval; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radium; United States; United States Food and Drug Administration	2013
Prostate cancer: radium-223: a new treatment option for bone-metastatic CRPC. Nature reviews. Urology, 2013, Volume: 10, Issue:11 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Radium-223 in prostate cancer. The New England journal of medicine, 2013, 10-24, Volume: 369, Issue:17 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2013
Prostate cancer, version 1.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 2013, Dec-01, Volume: 11, Issue:12 Topics: Bone Neoplasms; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Radioisotopes; Radium; Recurrence	2013
Re: alpha emitter radium-223 and survival in metastatic prostate cancer. The Journal of urology, 2014, Volume: 191, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2014
To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Apr-10, Volume: 32, Issue:11 Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Castration; Denosumab; Diagnosis, Differential; Diphosphonates; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Radium; RANK Ligand	2014
Prostate cancer bone metastases: not so systemic after all. The Lancet. Oncology, 2014, Volume: 15, Issue:7 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2014
Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223. Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:4 Topics: Bone Neoplasms; Dose Fractionation, Radiation; Humans; Male; Pain Management; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Radium; Risk Assessment	2014
Radium-223 vs EBRT for multiple painful bone metastases: is less more? Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:4 Topics: Bone Neoplasms; Dose Fractionation, Radiation; Humans; Male; Pain Management; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy; Radium; Risk Assessment	2014
Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer. Future oncology (London, England), 2015, Volume: 11, Issue:2 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Pain Management; Patient Selection; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium	2015
Radium-223 dichloride for the treatment of metastatic prostate cancer. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:14 Topics: Bone and Bones; Bone Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic	2014
Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods. Medical physics, 2014, Volume: 41, Issue:11 Topics: Algorithms; Beta Particles; Bone Neoplasms; Computer Simulation; DNA; DNA Damage; DNA Repair; Humans; Lutetium; Monte Carlo Method; Neoplasm Metastasis; Palliative Care; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium; Samarium; Strontium Radioisotopes	2014
Effect of docetaxel on safety and efficacy of radium-223. The Lancet. Oncology, 2014, Volume: 15, Issue:12 Topics: Bone Neoplasms; Docetaxel; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Taxoids	2014
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223. Scandinavian journal of urology, 2015, Volume: 49, Issue:3 Topics: Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Male; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiotherapy; Radium; Tomography, X-Ray Computed; Treatment Outcome	2015
Targeted radionuclides for prostate cancer bone metastases. Urologic oncology, 2015, Volume: 33, Issue:1 Topics: Bone Neoplasms; Clinical Trials, Phase IV as Topic; Double-Blind Method; Humans; Male; Multicenter Studies as Topic; Neoplasm Metastasis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Randomized Controlled Trials as Topic	2015
One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer biotherapy & radiopharmaceuticals, 2015, Volume: 30, Issue:5 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Bone Neoplasms; Disease Progression; Humans; Male; Middle Aged; Pain; Pain Measurement; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retrospective Studies; Treatment Outcome	2015
Re: Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. The Journal of urology, 2015, Volume: 193, Issue:3 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2015
Real-time scintigraphic assessment of intravenous radium-223 administration for quality control. BioMed research international, 2015, Volume: 2015 Topics: Administration, Intravenous; Alpha Particles; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality Control; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Retrospective Studies	2015
Determination of photon emission probabilities for the main gamma-rays of ²²³Ra in equilibrium with its progeny. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2015, Volume: 101 Topics: Bone Neoplasms; Gamma Rays; Germanium; Half-Life; Humans; Male; Photons; Probability; Prostatic Neoplasms, Castration-Resistant; Radium; Spectrometry, Gamma	2015
Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report. BMC cancer, 2015, May-07, Volume: 15 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Humans; Kallikreins; Male; Pain; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Tomography, Emission-Computed; Treatment Outcome	2015
Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2015 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2015
Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Odds Ratio; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Reproducibility of Results; Research Design; Tomography, X-Ray Computed; Treatment Outcome	2015
Radium-223: Optimizing Treatment and Research of Osteoblastic Bone Metastasis. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:7 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2015
Radiation Dose and Hazard Assessment of Potential Contamination Events During Use of 223Ra Dichloride in Radionuclide Therapy. Health physics, 2015, Volume: 109, Issue:3 Topics: Air Pollutants, Radioactive; Bone Neoplasms; Humans; Inhalation Exposure; Male; Occupational Exposure; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radiation Injuries; Radioactive Hazard Release; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Skin	2015
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1 Topics: Adult; Alpha Particles; Biological Transport; Bone Neoplasms; Humans; Kinetics; Male; Organotechnetium Compounds; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiometry; Radium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2016
Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2015, Volume: 13, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Brachytherapy; Clinical Decision-Making; Docetaxel; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Treatment Outcome	2015
Palliation of Extensive Metastatic Bone Disease With 223Ra-Dichloride α-Particle Therapy in a Patient With Malignant Hereditary Paraganglioma-Pheochromocytoma Syndrome With SDHB Mutation. Clinical nuclear medicine, 2016, Volume: 41, Issue:2 Topics: Adult; Alpha Particles; Bone Neoplasms; Female; Humans; Neoplastic Syndromes, Hereditary; Palliative Care; Paraganglioma; Radioisotopes; Radiopharmaceuticals; Radium; Succinate Dehydrogenase	2016
The timing of radium-223 therapy in castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2015, Volume: 13, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brachytherapy; Combined Modality Therapy; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment; Time Factors; Treatment Outcome	2015
New developments in metastatic prostate cancer therapy. The Practitioner, 2015, Volume: 259, Issue:1781 Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiotherapy; Radium; Risk Assessment; Taxoids; Therapies, Investigational; United Kingdom	2015
Radium-223 dichloride therapy in breast cancer with osseous metastases. BMJ case reports, 2015, Nov-18, Volume: 2015 Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Off-Label Use; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed; Treatment Outcome	2015
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up. Annals of nuclear medicine, 2016, Volume: 30, Issue:2 Topics: Aged; Bone Neoplasms; Chlorides; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radiometry; Radium	2016
Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:5 Topics: Alpha Particles; Animals; Antineoplastic Agents; Autoradiography; Bone Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Tissue Distribution; Tumor Microenvironment; Whole-Body Irradiation	2016
[Good risk/benefit profile of treatment with confirmed alpha emitter]. Revue medicale suisse, 2015, Nov-04, Volume: 11, Issue:493 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2015
[Radium dichloride-223 improves symptoms including in the daily clinic]. Revue medicale suisse, 2015, Nov-04, Volume: 11, Issue:493 Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2015
NICE guidance on radium-223 dichloride for hormone-relapsed prostate cancer with bone metastases. The Lancet. Oncology, 2016, Volume: 17, Issue:3 Topics: Aged; Bone Neoplasms; Disease-Free Survival; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Risk Assessment; Survival Rate; Treatment Outcome; United Kingdom	2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium; Tomography, X-Ray Computed; Tumor Burden	2016
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate	2016
When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer. Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:1 Topics: Biomarkers, Tumor; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Humans; Male; Neoplasm Metastasis; Patient Selection; Practice Guidelines as Topic; Prognosis; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Time-to-Treatment; Treatment Outcome	2016
Prostate-Specific Antigen Flare Phenomenon During Clinical genitourinary cancer, 2016, Volume: 14, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium	2016
Dosing, administration, and safety of radium-223: How I do it. The Canadian journal of urology, 2016, Volume: 23, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Canada; Humans; Legislation, Drug; Male; Patient Education as Topic; Patient Selection; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Safety; United States	2016
Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California. The Canadian journal of urology, 2016, Volume: 23, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Clinical Trials, Phase II as Topic; Congresses as Topic; Health Services; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium	2016
68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Antineoplastic Agents; Bone Neoplasms; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radium; Treatment Outcome	2016
[Therapy of bone metastases with radium-223. German guidelines]. Nuklearmedizin. Nuclear medicine, 2016, Sep-26, Volume: 55, Issue:5 Topics: Bone Neoplasms; Evidence-Based Medicine; Germany; Nuclear Medicine; Practice Guidelines as Topic; Radiopharmaceuticals; Radiotherapy; Radium; Treatment Outcome	2016
Radium-223 in prostate cancer: emitting the right signals. The Lancet. Oncology, 2016, Volume: 17, Issue:9 Topics: Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radium	2016
Prostate cancer: Radium-223 safe in combination. Nature reviews. Urology, 2016, Volume: 13, Issue:10 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium	2016
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer. Oncology, 2016, Volume: 91, Issue:5 Topics: Abdominal Neoplasms; Abiraterone Acetate; Aged; Antineoplastic Agents; Benzamides; Bone Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Humans; Lymphatic Metastasis; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Retreatment; Retrospective Studies; Survival Rate; Taxoids	2016
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:3 Topics: Aged; Bone Neoplasms; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Radium; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome	2017
Exceptional Duration of Radium-223 in Prostate Cancer With a BRCA2 Mutation. Clinical genitourinary cancer, 2017, Volume: 15, Issue:1 Topics: Bone Neoplasms; BRCA2 Protein; Humans; Male; Middle Aged; Mutation; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Treatment Outcome	2017
Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223. Urologia, 2017, Feb-03, Volume: 84, Issue:1 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Radium	2017
Acute Myeloid Leukemia After Radium-223 Therapy: Case Report. Clinical genitourinary cancer, 2017, Volume: 15, Issue:4 Topics: Aged; Bone Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Prostatic Neoplasms, Castration-Resistant; Radium	2017
[Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases]. Der Urologe. Ausg. A, 2017, Volume: 56, Issue:1 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Evidence-Based Medicine; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Symptom Assessment; Treatment Outcome	2017
A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary. Pathology oncology research : POR, 2017, Volume: 23, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Cancer Pain; Humans; Hungary; Male; Middle Aged; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Retrospective Studies	2017
Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223. Clinical genitourinary cancer, 2017, Volume: 15, Issue:3 Topics: Aged; Bone Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Male; Prostatic Neoplasms, Castration-Resistant; Radium	2017
223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct Carcinoma. Clinical nuclear medicine, 2017, Volume: 42, Issue:5 Topics: Aged; Bone Neoplasms; Carcinoma, Ductal; Humans; Male; Radiopharmaceuticals; Radium; Salivary Gland Neoplasms	2017
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database. Prostate cancer and prostatic diseases, 2017, Volume: 20, Issue:3 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Humans; Kallikreins; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radium; Retrospective Studies; Treatment Outcome	2017
Potential synergistic implications for stromal-targeted radiopharmaceuticals in bone-metastatic prostate cancer. Asian journal of andrology, 2011, Volume: 13, Issue:3 Topics: Bone Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neoplastic Stem Cells; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Stromal Cells	2011
Abiraterone and increased survival in metastatic prostate cancer. The New England journal of medicine, 2011, 08-25, Volume: 365, Issue:8 Topics: Antineoplastic Agents; Bone Neoplasms; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Radium	2011
Radiation-based approaches for therapy and palliation of advanced prostate cancer. Current opinion in urology, 2012, Volume: 22, Issue:3 Topics: Alpha Particles; Bone Neoplasms; Dose Fractionation, Radiation; Evidence-Based Medicine; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Strontium Radioisotopes; Treatment Outcome	2012
Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases. Nuclear medicine communications, 2012, Volume: 33, Issue:7 Topics: Alpha Particles; Bone Neoplasms; Chlorides; Feasibility Studies; Gamma Cameras; Humans; Phantoms, Imaging; Radioisotopes; Radium; Treatment Outcome	2012
Radium-223: down to the bone, and less is more. Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
An alpha edge? Oncology (Williston Park, N.Y.), 2012, Volume: 26, Issue:4 Topics: Alpha Particles; Bone Neoplasms; Humans; Male; Prostatic Neoplasms; Radiation Protection; Radiopharmaceuticals; Radium	2012
Molecular radiotherapy. Clinical medicine (London, England), 2012, Volume: 12, Issue:4 Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Humans; Iodine Radioisotopes; Lymphoma; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radiotherapy; Radium; Strontium Radioisotopes; Synovial Membrane	2012
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases. Clinical genitourinary cancer, 2013, Volume: 11, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Docetaxel; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Pain Management; Palliative Care; Proportional Hazards Models; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	2013
Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients. European urology, 2013, Volume: 63, Issue:2 Topics: Adenocarcinoma; Alpha Particles; Bone Neoplasms; Humans; Kallikreins; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radium	2013
(223)Ra targets skeletal metastases and spares normal tissue. The Lancet. Oncology, 2002, Volume: 3, Issue:8 Topics: Animals; Bone and Bones; Bone Neoplasms; Disease Models, Animal; Humans; Radiation Injuries; Radiotherapy; Radium; Rats; Sensitivity and Specificity	2002
A consistent two-mutation model of bone cancer for two data sets of radium-injected beagles. Journal of radiological protection : official journal of the Society for Radiological Protection, 2002, Volume: 22, Issue:3A Topics: Animals; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Injections; Mutagenesis; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Dosage; Radium	2002
Is there a difference in radionuclide-induced bone tumor sensitivity between male and female beagles? Health physics, 1999, Volume: 77, Issue:2 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Female; Humans; Linear Models; Male; Neoplasms, Radiation-Induced; Plutonium; Radium; Sex Factors	1999
Radioactivity and the human skeleton. The American journal of roentgenology, radium therapy, and nuclear medicine, 1958, Volume: 80, Issue:5 Topics: Bone and Bones; Bone Neoplasms; Humans; Neoplasms; Radioactivity; Radium	1958
[Radiation induced bone tumors after thorium-X treatment]. Monatsschrift fur Kinderheilkunde, 1962, Volume: 110 Topics: Bone and Bones; Bone Neoplasms; Humans; Neoplasms; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Injuries; Radium; Sarcoma; Thorium	1962
Development of osteogenic sarcoma in a radium dial painter thirty-seven years after the end of exposure. The American journal of medicine, 1962, Volume: 32 Topics: Bone Neoplasms; Femur; Humans; Medical Records; Neoplasms; Occupational Diseases; Osteosarcoma; Radium; Sarcoma; Tibia	1962
THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. II. A REVIEW OF SOME FACTORS AFFECTING THE RADIATION DAMAGE TO BONE FROM INGESTED RADIUM. The British journal of radiology, 1964, Volume: 37 Topics: Bone Diseases; Bone Neoplasms; Humans; Metabolism; Radiation Injuries; Radioisotopes; Radiometry; Radium	1964
THE CONCENTRATION OF RA-226, RA-228, PB-210, LEAD AND FLUORIDE IN HUMAN BONE FROM INDIVIDUALS WITH AN OSTEOGENIC SARCOMA. ANL-6769. ANL, 1963 Topics: Bone and Bones; Bone Neoplasms; Fluorides; Humans; Lead; Metabolism; Neoplasms; Neoplasms, Radiation-Induced; Osteosarcoma; Phosphates; Radioisotopes; Radium; Sarcoma	1963
RADIUM-226, RADIUM-228, LEAD-210, AND FLUORINE IN PERSONS WITH OSTEOGENIC SARCOMA. Science (New York, N.Y.), 1964, Jun-26, Volume: 144, Issue:3626 Topics: Bone and Bones; Bone Neoplasms; Chemistry Techniques, Analytical; Fluorides; Fluorine; Humans; Lead; Osteosarcoma; Radioisotopes; Radium; Sarcoma	1964
OCCUPATIONAL HAZARD. JAMA, 1964, Nov-23, Volume: 190 Topics: Bone Neoplasms; Connecticut; Femur; Fibrosarcoma; Forearm; Giant Cell Tumors; Humans; Ilium; Knee Joint; Neoplasms; Neoplasms, Radiation-Induced; New Jersey; Occupational Diseases; Osteosarcoma; Osteosclerosis; Pelvic Bones; Radiation Genetics; Radiation Injuries; Radiography; Radium; Sarcoma; Skull; Spine; Thorium	1964
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY. Archives of otolaryngology (Chicago, Ill. : 1960), 1964, Volume: 80 Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma	1964
RADIATION-INDUCED CARCINOMA OF THE MASTOID. Archives of otolaryngology (Chicago, Ill. : 1960), 1965, Volume: 81 Topics: Bone Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Humans; Mastoid; Neoplasms; Neoplasms, Radiation-Induced; Pathology; Photomicrography; Radiography; Radium; Temporal Bone	1965
LONG-TERM EFFECTS OF RADIUM DEPOSITION IN MAN: PROGRESS REPORT. ANL-6839. ANL, 1965 Topics: Bone Neoplasms; Humans; Male; Neoplasms; Neoplasms, Radiation-Induced; Radiation; Radiation Injuries; Radium; Research Report; Time	1965
MALIGNANT HEMANGIOENDOTHELIOMA OF BONE: REPORT OF TWO CASES AND REVIEW OF THE LITERATURE. The Journal of bone and joint surgery. American volume, 1965, Volume: 47 Topics: Bone Neoplasms; Diagnosis, Differential; Femoral Neoplasms; Hemangioendothelioma; Humans; Neoplasms; Pathology; Radiography; Radium; Radius; Sarcoma; Sarcoma, Ewing; Surgical Procedures, Operative; Ulnar Nerve	1965
Studies of radium in human bone. Radiology, 1951, Volume: 56, Issue:1 Topics: Bone Neoplasms; Humans; Neoplasms; Osteosarcoma; Radium; Sarcoma	1951
[Reports from radium clinics. "Rheumatism" and bone metastases, specifically from breast cancer]. Ugeskrift for laeger, 1950, Dec-21, Volume: 112, Issue:51 Topics: Bone Neoplasms; Breast; Breast Neoplasms; Humans; Neoplasms; Radium; Rheumatic Diseases	1950
Two-mutation models for bone cancer due to radium, strontium and plutonium. Radiation research, 2004, Volume: 162, Issue:2 Topics: Animals; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Models, Genetic; Mutation; Neoplasms, Radiation-Induced; Plutonium; Radium; Strontium	2004
Illinois bone tumor death certificate study. Annual report - Division of Biological and Medical Research, Argonne National Laboratory. Argonne National Laboratory. Division of Biological and Medical Research, 1960, Volume: ANL-6264 Topics: Bone and Bones; Bone Neoplasms; Death Certificates; Humans; Illinois; Neoplasms; Radium	1960
Bone cancer risk in mice exposed to 224Ra: protraction effects from promotion. Radiation and environmental biophysics, 2005, Volume: 44, Issue:1 Topics: Animals; Bone Neoplasms; Female; Mice; Models, Biological; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Risk Assessment; Thorium	2005
Comments on "Two-mutation models for bone cancer due to radium, strontium and plutonium" by Bijwaard et al. (Radiat. Res. 162, 171-184, 2004). Radiation research, 2005, Volume: 164, Issue:6 Topics: Animals; Bone Neoplasms; Dogs; Humans; Models, Biological; Mutation; Osteosarcoma; Plutonium; Radium; Reproducibility of Results; Strontium	2005
Mechanistic models of bone cancer induction by radium and plutonium in animals compared to humans. Radiation protection dosimetry, 2006, Volume: 122, Issue:1-4 Topics: Animals; Bone Neoplasms; Computer Simulation; Dogs; Dose-Response Relationship, Radiation; Humans; Mice; Models, Biological; Neoplasms, Radiation-Induced; Plutonium; Radiation Dosage; Radium; Rats; Risk Assessment; Risk Factors; Species Specificity	2006
Osteochondromas and growth retardation secondary to externally or internally administered radiation in childhood. Pediatric radiology, 2007, Volume: 37, Issue:3 Topics: Bone and Bones; Bone Development; Bone Marrow Transplantation; Bone Neoplasms; Child; Growth Disorders; Humans; Infant; Neoplasms; Osteochondroma; Radiation Dosage; Radiopharmaceuticals; Radiotherapy; Radium; Thorium; Transplantation Conditioning; Tuberculosis, Osteoarticular; Whole-Body Irradiation	2007
Radium-223 for men with hormone-refractory prostate cancer and bone metastases. The Lancet. Oncology, 2007, Volume: 8, Issue:7 Topics: Alkaline Phosphatase; Bone Neoplasms; Drug Resistance, Neoplasm; Humans; Male; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radium	2007
Determination of 226Ra in cheese produced in the rural area of Pernambuco-Brazil. Bulletin of environmental contamination and toxicology, 2007, Volume: 79, Issue:3 Topics: Bone Neoplasms; Brazil; Carcinoma; Cheese; Environmental Monitoring; Epidemiological Monitoring; Food Contamination, Radioactive; Radioactive Pollutants; Radium; Risk Assessment; Sarcoma; Skull Neoplasms	2007
The risk of bone cancer in man from internally deposited radium. The British journal of radiology, 1967, Volume: 40, Issue:475 Topics: Bone Neoplasms; Environmental Exposure; Humans; Occupational Diseases; Radium	1967
Comparison of the carcinogenicity of radium and bone-seeking actinides. Health physics, 1984, Volume: 46, Issue:6 Topics: Actinoid Series Elements; Alpha Particles; Animals; Bone and Bones; Bone Neoplasms; Dogs; Models, Biological; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Relative Biological Effectiveness; Risk; Time Factors	1984
The role of time-factor and RBE for the induction of osteosarcomas by incorporated short-lived bone-seekers. Health physics, 1983, Volume: 44 Suppl 1 Topics: Animals; Bone Neoplasms; Lutetium; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radioisotopes; Radium; Relative Biological Effectiveness; Strontium Radioisotopes; Thorium; Time Factors	1983
Sites of incidence of osteosarcoma in the long bones of man and the beagle. Health physics, 1983, Volume: 44 Suppl 1 Topics: Alpha Particles; Animals; Bone and Bones; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Humans; Male; Middle Aged; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radium; Thorium	1983
[Theoretical evaluation of the expected yield of osteosarcomas after radium isotope intake]. Gigiena i sanitariia, 1983, Issue:5 Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Mathematics; Models, Biological; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Risk	1983
226Ra induced bone-cancers: the effects of a delayed Na-alginate treatment. International journal of radiation biology and related studies in physics, chemistry, and medicine, 1983, Volume: 43, Issue:3 Topics: Alginates; Animals; Bone Neoplasms; Decontamination; Male; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Time Factors; Tissue Distribution	1983
Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino mice. Radiation research, 1983, Volume: 95, Issue:3 Topics: Alpha Particles; Americium; Animals; Bone Neoplasms; Californium; Dose-Response Relationship, Radiation; Female; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Models, Biological; Neoplasms, Radiation-Induced; Plutonium; Radioactivity; Radium; Risk; Sarcoma, Experimental; Sex Factors	1983
Radium retention in mature beagles injected at 5 years of age. Radiation research, 1983, Volume: 94, Issue:1 Topics: Age Factors; Animals; Body Burden; Bone and Bones; Bone Neoplasms; Dogs; Feces; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radium; Radon; Spectrometry, Gamma; Time Factors	1983
Chronic radium intoxication: radium osteonecrosis and cancer in relation to 226Ra burdens. Health physics, 1983, Volume: 44 Suppl 1 Topics: Background Radiation; Body Burden; Bone Neoplasms; Chronic Disease; Femur; Humans; Neoplasms, Radiation-Induced; New Jersey; Occupational Diseases; Osteoradionecrosis; Radiation Injuries; Radium	1983
Cells at risk for the production of bone tumors in radium exposed individuals: an electron microscope study. Health physics, 1983, Volume: 44 Suppl 1 Topics: Aged; Bone Marrow; Bone Neoplasms; Cell Nucleus; Female; Femoral Neoplasms; Femur; Humans; Male; Microscopy, Electron; Neoplasms, Radiation-Induced; Occupational Diseases; Radium; Risk	1983
Dose-response relationships for radium-induced bone sarcomas. Health physics, 1983, Volume: 44 Suppl 1 Topics: Adult; Age Factors; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Male; Middle Aged; Neoplasms, Radiation-Induced; Occupational Diseases; Radium; Risk; Sarcoma; Sex Factors; Time Factors; United States	1983
Follow-up study of late effects in 224Ra treated ankylosing spondylitis patients. Health physics, 1983, Volume: 44 Suppl 1 Topics: Aged; Bone Neoplasms; Cataract; Female; Follow-Up Studies; Germany, West; Humans; Male; Middle Aged; Neoplasms, Radiation-Induced; Radiotherapy Dosage; Radium; Risk; Spondylitis, Ankylosing	1983
Lifetime bone cancer dose-response relationships in beagles and people from skeletal burdens of 226Ra and 90Sr. Health physics, 1983, Volume: 44 Suppl 1 Topics: Animals; Body Burden; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Humans; Life Expectancy; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radium; Relative Biological Effectiveness; Risk; Strontium Radioisotopes	1983
Comparison of radiological changes in humans and beagles with skeletal deposits of radium. Health physics, 1983, Volume: 44 Suppl 1 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Humans; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Occupational Diseases; Osteoradionecrosis; Radiation Injuries, Experimental; Radiography; Radium; Sarcoma	1983
Plutonium-induced osteosarcomas in the St. Bernard. Radiation research, 1981, Volume: 88, Issue:1 Topics: Animals; Body Weight; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiation Tolerance; Radium; Time Factors	1981
Lifetime studies of 226Ra and 90Sr toxicity in beagles--a status report. Radiation research, 1981, Volume: 86, Issue:3 Topics: Animals; Body Burden; Bone Marrow Diseases; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation Injuries, Experimental; Radium; Soft Tissue Neoplasms; Strontium Radioisotopes; Time Factors; Toxicology	1981
Dose-response relationships for bone tumors in beagles exposed to 226Ra and 90Sr. Health physics, 1981, Volume: 40, Issue:6 Topics: Animals; Bone Neoplasms; Diet; Dogs; Dose-Response Relationship, Radiation; Female; Humans; Injections, Intravenous; Mice; Neoplasms, Radiation-Induced; Radium; Strontium Radioisotopes	1981
Bone cancer from radium: canine dose response explains data for mice and humans. Science (New York, N.Y.), 1980, Apr-04, Volume: 208, Issue:4439 Topics: Animals; Bone Neoplasms; Disease Models, Animal; Dogs; Dose-Response Relationship, Radiation; Humans; Mice; Neoplasms, Radiation-Induced; Radium; Species Specificity	1980
Radium in drinking water and the risk of death from bone cancer among Ontario youths. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1994, Sep-01, Volume: 151, Issue:5 Topics: Adolescent; Adult; Background Radiation; Bone Neoplasms; Child; Environmental Exposure; Female; Humans; Male; Neoplasms, Radiation-Induced; Ontario; Radium; Regression Analysis; Risk Factors; Water Supply	1994
Relative effectiveness of 239Pu and some other internal emitters for bone cancer induction in beagles. Health physics, 1994, Volume: 67, Issue:4 Topics: Animals; Bone Neoplasms; Dogs; Female; Male; Neoplasms, Radiation-Induced; Plutonium; Radium	1994
Bone sarcoma characteristics and distribution in beagles injected with radium-226. Radiation research, 1994, Volume: 137, Issue:3 Topics: Animals; Bone Neoplasms; Cohort Studies; Dogs; Dose-Response Relationship, Radiation; Female; Incidence; Male; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Osteosarcoma; Radium	1994
Comparing bone sarcoma induction in humans from 224Ra and 226+228Ra. Health physics, 1993, Volume: 65, Issue:5 Topics: Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Radium; Sarcoma; Thorium	1993
Radium in drinking water and risk of bone cancer in Ontario youths: a second study and combined analysis. Occupational and environmental medicine, 1996, Volume: 53, Issue:5 Topics: Adolescent; Adult; Bone Neoplasms; Case-Control Studies; Child; Dose-Response Relationship, Radiation; Environmental Exposure; Female; Humans; Male; Models, Biological; Neoplasms, Radiation-Induced; Odds Ratio; Ontario; Osteosarcoma; Radium; Water Pollution, Radioactive	1996
The biological effects of radium-224 injected into dogs. Radiation research, 1996, Volume: 146, Issue:2 Topics: Animals; Bone Neoplasms; Cataract; Dogs; Female; Kidney Neoplasms; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nose Neoplasms; Radiation Dosage; Radium	1996
Radium dial workers: issues concerning dose response and modeling. Radiation research, 1997, Volume: 147, Issue:6 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Models, Biological; Neoplasms, Radiation-Induced; Occupational Exposure; Radium; Sarcoma	1997
Relationship of natural incidence and radiosensitivity for bone cancer in dogs. Health physics, 1997, Volume: 73, Issue:4 Topics: Animals; Bone Neoplasms; Dog Diseases; Dogs; Incidence; Neoplasms, Radiation-Induced; Plutonium; Radiation Tolerance; Radium; Risk Factors; Sarcoma; Species Specificity	1997
Bone tumor location in dogs given skeletal irradiation by 239Pu or 226Ra. Health physics, 1997, Volume: 73, Issue:4 Topics: Aging; Americium; Animals; Bone Neoplasms; Californium; Dogs; Neoplasms, Radiation-Induced; Organ Specificity; Plutonium; Radium; Thorium	1997
Does age of the host affect growth rates of skeletal malignancies? Health physics, 1998, Volume: 75, Issue:4 Topics: Age Factors; Animals; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Lead Radioisotopes; Neoplasms, Radiation-Induced; Probability; Radium; Spinal Neoplasms	1998
Studies of U.S. radium dial workers: an epidemiological classic. Radiation research, 1998, Volume: 150, Issue:5 Suppl Topics: Anemia; Bone Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lymphoid Tissue; Neoplasms, Radiation-Induced; Occupational Exposure; Osteitis; Osteosarcoma; Radium; United States	1998
Relative radiosensitivity of bone tumor induction among beagles as a function of age at injection of 239Pu or 226Ra. Health physics, 1999, Volume: 76, Issue:1 Topics: Age Factors; Animals; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Neoplasms, Radiation-Induced; Plutonium; Radium	1999
Some problems in the skeletal dosimetry of bone-seeking radionuclides. Health physics, 1999, Volume: 76, Issue:4 Topics: Age Factors; Animals; Bone and Bones; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Humans; Mice; Microspheres; Models, Biological; Plutonium; Radioisotopes; Radiometry; Radium; Strontium Radioisotopes; Yttrium Radioisotopes	1999
Malignancies in patients treated with high doses of radium-224. Radiation research, 1999, Volume: 152, Issue:6 Suppl Topics: Adolescent; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Kidney Neoplasms; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms, Radiation-Induced; Radium; Sarcoma; Spondylitis, Ankylosing; Urinary Bladder Neoplasms	1999
Late effects in ankylosing spondylitis patients treated with 224Ra. Radiation research, 1999, Volume: 152, Issue:6 Suppl Topics: Adult; Aged; Bone Neoplasms; Female; Follow-Up Studies; Humans; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms, Radiation-Induced; Radium; Spondylitis, Ankylosing	1999
Induction of malignant bone tumors in radium-224 patients: risk estimates based on the improved dosimetry. Radiation research, 2000, Volume: 153, Issue:1 Topics: Adolescent; Adult; Age Distribution; Age Factors; Bone Neoplasms; Child; Chordoma; Cohort Studies; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Germany; Humans; Incidence; Likelihood Functions; Lymphoma; Male; Neoplasms, Radiation-Induced; Radiometry; Radium; Risk Assessment; Sarcoma; Sex Distribution; Thorium	2000
An analysis of bone and head sinus cancers in radium dial painters using a two-mutation carcinogenesis model. Journal of radiological protection : official journal of the Society for Radiological Protection, 2000, Volume: 20, Issue:2 Topics: Adult; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Neoplasms, Radiation-Induced; Occupational Diseases; Paranasal Sinus Neoplasms; Radiation Dosage; Radium	2000
Does body size contribute to sensitivity of bone tumor induction by radionuclide exposure? Health physics, 2000, Volume: 79, Issue:2 Topics: Animals; Body Constitution; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Neoplasms, Radiation-Induced; Plutonium; Radiation Dosage; Radioisotopes; Radium; Regression Analysis; Sensitivity and Specificity; Strontium Radioisotopes; Thorium; Time	2000
Effective thresholds for induction of skeletal malignancies by radionuclides. Health physics, 2000, Volume: 79, Issue:6 Topics: Americium; Animals; Bone Neoplasms; Dogs; Neoplasms, Radiation-Induced; Plutonium; Radium; Strontium Radioisotopes; Thorium	2000
Bone cancer risk. Journal of radiological protection : official journal of the Society for Radiological Protection, 2001, Volume: 21, Issue:1 Topics: Bone Neoplasms; Environmental Exposure; Humans; Neoplasms, Radiation-Induced; Occupational Diseases; Radium; Risk Factors; Strontium	2001
Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer research, 2002, Jun-01, Volume: 62, Issue:11 Topics: Alpha Particles; Animals; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Humans; Mice; Mice, Inbred BALB C; Radium; Rats; Rats, Nude; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2002
Late effects after incorporation of the short-lived alpha-emitters 224Ra and 227Th in mice. Health physics, 1978, Volume: 35, Issue:1 Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Fibroma; Leukemia, Radiation-Induced; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Ossification, Heterotopic; Osteosarcoma; Radium; Sex Factors; Thorium; Time Factors	1978
Aspects of the dosimetry of alpha-emitting radionuclides in bone with particular emphasis on 226Ra and 239Pu. Physics in medicine and biology, 1977, Volume: 22, Issue:1 Topics: Animals; Bone and Bones; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Humans; Leukemia; Mathematics; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiation Monitoring; Radium	1977
The osteosarcomogenic effectiveness of the short-lived 224Ra compared with that of the long-lived 226Ra in mice. Radiation research, 1977, Volume: 70, Issue:2 Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Half-Life; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radium	1977
Planimetric evaluation and comparison of roentgenograms of osteogenic sarcomas induced by 226Ra and 224Ra in mice. Neoplasma, 1977, Volume: 24, Issue:3 Topics: Animals; Bone Neoplasms; Female; Injections; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radiography; Radium; Sarcoma, Experimental	1977
3H-TDR labelling of osteoprogenitor cells after 226RA incorporation in mice. Acta radiologica: therapy, physics, biology, 1977, Volume: 16, Issue:3 Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Cell Division; DNA; Dose-Response Relationship, Radiation; Female; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Thymidine; Tritium	1977
Measurements of endosteal surface areas in human long bones: relationship to sites of occurrence of osteosarcoma. The British journal of radiology, 1977, Volume: 50, Issue:599 Topics: Anthropometry; Bone and Bones; Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Osteosarcoma; Radionuclide Imaging; Radiotherapy; Radiotherapy Dosage; Radium	1977
Skeletal effects following 224Ra injections into humans. Health physics, 1978, Volume: 35, Issue:1 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Exostoses; Female; Growth; Growth Disorders; Humans; Male; Middle Aged; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Sarcoma; Tooth; Tooth Fractures	1978
The radiobiological significance of the studies with 224Ra and thorotrast. Health physics, 1978, Volume: 35, Issue:1 Topics: Adolescent; Adult; Anemia, Aplastic; Bone Neoplasms; Hemangioendothelioma; Humans; Leukemia, Radiation-Induced; Liver Neoplasms; Lung Neoplasms; Multiple Myeloma; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Thorium Dioxide	1978
Dose-response relationships for female radium dial workers. Radiation research, 1978, Volume: 76, Issue:2 Topics: Age Factors; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Head and Neck Neoplasms; Humans; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Radium; Radon; Registries; Retrospective Studies; Time Factors	1978
Competitive radiation-induced carcinogenesis: an analysis of data from beagle dogs exposed to 226Ra and 90Sr. Health physics, 1979, Volume: 36, Issue:3 Topics: Age Factors; Animals; Bone Neoplasms; Diet; Dogs; Dose-Response Relationship, Radiation; Female; Injections, Intravenous; Male; Myeloproliferative Disorders; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Respiration; Strontium Radioisotopes; Yttrium Radioisotopes	1979
Osteosarcoma induced by short-lived bone-seeking alpha emitters in mice: the role of age. Environmental research, 1979, Volume: 18, Issue:1 Topics: Age Factors; Alpha Particles; Animals; Bone Neoplasms; Female; Injections, Intraperitoneal; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Thorium	1979
The New Jersey radium dial painters: a classic in occupational carcinogenesis. Bulletin of the history of medicine, 1978,Winter, Volume: 52, Issue:4 Topics: Adult; Anemia, Aplastic; Bone Neoplasms; Female; History, 20th Century; Humans; Jaw Diseases; Male; Neoplasms, Radiation-Induced; New Jersey; Occupational Diseases; Osteonecrosis; Osteoradionecrosis; Paint; Radium	1978
Bone tumors in thorotrast patients. Environmental research, 1979, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Denmark; Dose-Response Relationship, Radiation; Female; Germany; Humans; Male; Middle Aged; Neoplasms, Radiation-Induced; Plutonium; Portugal; Radium; Risk; Sarcoma; Thorium Dioxide	1979
Exostoses induced by 224Ra (ThX) in children. European journal of pediatrics, 1979, Volume: 132, Issue:4 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Exostoses; Female; Humans; Infant; Male; Neoplasms, Radiation-Induced; Radium; Sarcoma; Sex Factors	1979
Bone cancer among female radium dial workers. Latency periods and incidence rates by time after exposure: brief communication. Journal of the National Cancer Institute, 1978, Volume: 60, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Humans; Middle Aged; Neoplasms, Radiation-Induced; Occupational Diseases; Radiation Dosage; Radium; Time Factors; United States	1978
[Animal experimental studies with radium 224]. Zeitschrift fur Orthopadie und ihre Grenzgebiete, 1978, Volume: 116, Issue:4 Topics: Alkaline Phosphatase; Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Mice; Neoplasms, Radiation-Induced; Radium; Risk; Thorium	1978
Current status of the study of 226Ra and 228Ra in humans at the center for human radiobiology. Health physics, 1978, Volume: 35, Issue:1 Topics: Bone Neoplasms; Carcinoma; Humans; Mastoid; Neoplasms, Radiation-Induced; Occupational Diseases; Paranasal Sinus Neoplasms; Radium; Sarcoma; Skull Neoplasms	1978
A theory of the induction of bone cancer by alpha radiation. Radiation research, 1977, Volume: 71, Issue:1 Topics: Alpha Particles; Animals; Bone Neoplasms; Cell Survival; Dogs; Dose-Response Relationship, Radiation; Humans; Mathematics; Methods; Models, Biological; Neoplasms, Radiation-Induced; Probability; Radium; Species Specificity; Statistics as Topic; Time Factors	1977
Radiographic features of bone in several strains of laboratory mice and of their tumours induced by bone-seeking radionuclides. Journal of anatomy, 1976, Volume: 122, Issue:Pt 2 Topics: Aging; Animals; Bone and Bones; Bone Neoplasms; Fibrosarcoma; Hemangiosarcoma; Lymphoma; Mice; Mice, Inbred A; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiography; Radium; Species Specificity; Strontium Radioisotopes	1976
Experimental induction of bone tumors by short-lived bone-seeking radionuclides. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1976, Issue:54 Topics: Animals; Bone Diseases, Developmental; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Half-Life; Male; Mice; Neoplasms, Experimental; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Skull Neoplasms; Spinal Neoplasms; Thorium; Time Factors	1976
Viruses in osteosarcomas induced by 226Ra. A study of the induction of bone tumours in mice. International journal of radiation biology and related studies in physics, chemistry, and medicine, 1975, Volume: 28, Issue:1 Topics: Animals; Bone Neoplasms; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Oncogenic Viruses; Osteosarcoma; Radium; Virus Replication	1975
Interspecies scaling of risk for radiation-induced bone cancer. International journal of radiation biology, 1990, Volume: 57, Issue:5 Topics: Animals; Bone Neoplasms; Dogs; Humans; Mice; Neoplasms, Radiation-Induced; Radium; Risk; Species Specificity	1990
Dose and dose-rate dependence for bone sarcomas in radium-224 patients. International journal of radiation biology, 1990, Volume: 58, Issue:5 Topics: Bone Neoplasms; Dose-Response Relationship, Radiation; Humans; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Dosage; Radium; Spondylitis, Ankylosing	1990
Distribution of radium-induced bone cancers in beagles and comparison with humans. Health physics, 1991, Volume: 60, Issue:3 Topics: Animals; Body Burden; Bone and Bones; Bone Neoplasms; Dogs; Humans; Injections, Intravenous; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radium	1991
The influence of age at time of exposure to 226Ra or 239Pu on distribution, retention, postinjection survival, and tumor induction in beagle dogs. Radiation research, 1991, Volume: 125, Issue:3 Topics: Aging; Animals; Bone and Bones; Bone Neoplasms; Dogs; Injections, Intravenous; Neoplasms, Radiation-Induced; Plutonium; Radiation Injuries, Experimental; Radium	1991
Toxicity of 241Am in male C57BL mice: relative risk versus 226Ra. Radiation research, 1991, Volume: 126, Issue:2 Topics: Americium; Animals; Bone Neoplasms; Injections, Intraperitoneal; Life Expectancy; Male; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Radium; Risk	1991
The reverse protraction factor in the induction of bone sarcomas in radium-224 patients. Radiation research, 1990, Volume: 124, Issue:1 Suppl Topics: Adolescent; Adult; Bone Neoplasms; Female; Follow-Up Studies; Germany, West; Humans; Injections, Intravenous; Male; Neoplasms, Radiation-Induced; Osteosarcoma; Proportional Hazards Models; Radium; Spondylitis, Ankylosing; Time Factors; Tuberculosis, Osteoarticular	1990
Induction of lymphoma and osteosarcoma in mice by single and protracted low alpha doses. Health physics, 1990, Volume: 59, Issue:3 Topics: Alpha Particles; Animals; Bone Neoplasms; Female; Injections, Intraperitoneal; Lymphoma; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Dosage; Radium	1990
Scaling of fatal cancer risks from laboratory animals to man. Health physics, 1989, Volume: 57 Suppl 1 Topics: Animals; Bone Neoplasms; Diethylnitrosamine; Dogs; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Mice; Neoplasms; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Plutonium; Radium; Rats; Risk; Species Specificity	1989
Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates. Leukemia research, 1988, Volume: 12, Issue:5 Topics: Animals; Antibodies, Viral; Antigens, Viral; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Osteoma; Osteopetrosis; Radium; Retroviridae; Virus Activation	1988
Pathology of radiation-induced bone tumors. Leukemia research, 1986, Volume: 10, Issue:7 Topics: Animals; Bone Neoplasms; Humans; Mice; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Radium; Sarcoma; Time Factors	1986
The prediction of the relative toxicities of radium 224 and of radium 226 in the bones of mice using Monte Carlo techniques. The British journal of radiology, 1987, Volume: 60, Issue:715 Topics: Animals; Biometry; Bone and Bones; Bone Marrow; Bone Neoplasms; Mice; Monte Carlo Method; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Dosage; Radium	1987
Cancer incidence and lifespan vs. alpha-particle dose in beagles. Health physics, 1987, Volume: 52, Issue:5 Topics: Alpha Particles; Americium; Animals; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Longevity; Plutonium; Radium; Sarcoma, Experimental; Thorium	1987
Late effects of 226Ra, 224Ra and 239Pu in female mice of the ICR strain. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Mice; Mice, Inbred ICR; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radium; Risk; Time Factors	1985
Cancer risk from the lifetime intake of Ra and U isotopes. Health physics, 1985, Volume: 48, Issue:5 Topics: Alpha Particles; Bone Neoplasms; Cost-Benefit Analysis; Dose-Response Relationship, Radiation; Half-Life; Head and Neck Neoplasms; Humans; Leukemia, Radiation-Induced; Life Expectancy; Mathematics; Neoplasms, Radiation-Induced; Occupational Diseases; Radiation Dosage; Radium; Risk; Sarcoma; Soft Tissue Neoplasms; Uranium; Water Pollutants, Radioactive; Water Supply	1985
Metabolism of ingested U and Ra. Health physics, 1985, Volume: 48, Issue:5 Topics: Animals; Body Burden; Bone and Bones; Bone Neoplasms; Calcium; Humans; Intestinal Absorption; Kidney; Maximum Allowable Concentration; Models, Biological; Neoplasms, Radiation-Induced; Radiation Dosage; Radiation Injuries; Radium; Risk; Sarcoma; Uranium; Water Pollutants, Radioactive; Water Supply	1985
243,244Cm studies in C57BL/Do mice. Radiation research, 1985, Volume: 102, Issue:3 Topics: Animals; Bone and Bones; Bone Neoplasms; Curium; Female; Kinetics; Male; Mathematics; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Radium; Relative Biological Effectiveness; Sarcoma, Experimental	1985
Current (1984) status of the study of 226Ra and 228Ra in humans at the Center for Human Radiobiology. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Bone Neoplasms; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasms, Radiation-Induced; Occupational Diseases; Population Surveillance; Radiation Dosage; Radium; United States	1985
Bone sarcoma cumulative tumor rates in patients injected with 224Ra. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Follow-Up Studies; Germany, West; Humans; Male; Neoplasms, Radiation-Induced; Radium; Sarcoma; Spondylitis, Ankylosing; Thorium; Time Factors; Tuberculosis	1985
A proportional hazards analysis of bone sarcoma rates in German 224radium patients. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Follow-Up Studies; Germany, West; Humans; Male; Neoplasms, Radiation-Induced; Radiation Dosage; Radium; Sarcoma; Thorium	1985
224Ra: risk to bone and haematopoietic tissue in ankylosing spondylitis patients. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Bone Neoplasms; Female; Follow-Up Studies; Germany, West; Humans; Leukemia, Radiation-Induced; Male; Neoplasms, Radiation-Induced; Radiation Dosage; Radium; Risk; Spondylitis, Ankylosing; Thorium; Time Factors	1985
Relationship of bone composition to the location of radium-induced bone cancer. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Female; Neoplasms, Radiation-Induced; Radiation Dosage; Radium; Sarcoma, Experimental	1985
The osteosarcomogenic efficiency of low 224radium-doses in mice compared to that of the short-lived beta-emitting rare earth 177lutetium. Strahlentherapie. Sonderbande, 1985, Volume: 80 Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Lutetium; Mice; Neoplasms, Radiation-Induced; Radioisotopes; Radium; Sarcoma, Experimental; Thorium	1985
[Disturbance of bone growth after incorporation of 224Ra (thorium X) in mice (author's transl)]. Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1972, Volume: 56 Topics: Animals; Bone Development; Bone Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Radiation Injuries, Experimental; Radium; Sarcoma, Experimental; Thorium	1972
[Radiation pathology of the skeletal system]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1972 Topics: Animals; Bone and Bones; Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Osteoradionecrosis; Radiation Injuries, Experimental; Radium	1972
[Late lesions following incorporation of 224Ra in animal experiment]. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1972 Topics: Animals; Bone Neoplasms; Female; Germany, West; Male; Mice; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Osteosarcoma; Radioisotope Teletherapy; Radiotherapy Dosage; Radium; Sarcoma, Experimental; Sex Factors; Thorium; Time Factors	1972
Radionuclides and bone--from 226Ra to 90Sr. The British journal of radiology, 1974, Volume: 47, Issue:564 Topics: Adult; Air Pollution, Radioactive; Animals; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Dogs; Dose-Response Relationship, Drug; Energy Transfer; Humans; Infant; Male; Maximum Allowable Concentration; Neoplasms, Radiation-Induced; Radiation Dosage; Radiation Effects; Radiation Protection; Radiobiology; Radionuclide Imaging; Radiotherapy Dosage; Radium; Strontium Radioisotopes	1974
[Current indications for and use of high energy ionizing radiations]. La Revue du praticien, 1974, Nov-11, Volume: 24, Issue:51 Topics: Bone Neoplasms; Breast Neoplasms; Cesium; Cobalt Radioisotopes; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Iridium; Lymphoma; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms; Radiobiology; Radioisotope Teletherapy; Radium; Respiratory Tract Neoplasms; Skin Neoplasms; Spinal Cord Neoplasms; Urogenital Neoplasms	1974
Radiation dose-time relations for induction of osteosarcoma in mice and dogs and their bearing on maximal permissible burden of 90 Sr in man. Health physics, 1972, Volume: 23, Issue:6 Topics: Animals; Body Burden; Bone Neoplasms; Dogs; Dose-Response Relationship, Radiation; Environmental Exposure; Female; Humans; Maximum Allowable Concentration; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radium; Rats; Strontium Isotopes	1972
[Elapsed time for the appearance of skeletal neoplasms in animals and man due to radioactive isotopes]. Meditsinskaia radiologiia, 1973, Volume: 18, Issue:3 Topics: Animals; Bone Neoplasms; Cerium Isotopes; Dogs; Humans; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radioisotopes; Radium; Rats; Strontium Isotopes; Thorium; Time Factors	1973
Virus-like particles in 224Ra-induced murine osteosarcomas. Beitrage zur Pathologie, 1974, Volume: 152, Issue:2 Topics: Animals; Bone Neoplasms; Endoplasmic Reticulum; Female; Liver Neoplasms; Mice; Microscopy, Electron; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Sarcoma, Experimental; Viruses	1974
Morphological evaluation of 226Ra induced osteogenic sarcoma in mice;. Neoplasma, 1974, Volume: 21, Issue:6 Topics: Animals; Bone Neoplasms; Female; Mandibular Neoplasms; Mice; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radium; Skull Neoplasms; Spinal Neoplasms	1974
The skeletal dose from 224Ra following intravascular administration of thorotrast. Riso report, 1973, Issue:294 Topics: Body Burden; Bone and Bones; Bone Neoplasms; Colloids; Dose-Response Relationship, Radiation; Female; Humans; Liver; Male; Neoplasms, Radiation-Induced; Organ Specificity; Radiation Dosage; Radiation Effects; Radium; Sarcoma; Spleen; Thorium Dioxide	1973
[10-year statistics of cobalt 60 radiotherapy for carcinoma in private practice]. Strahlentherapie, 1972, Volume: 144, Issue:5 Topics: Adult; Age Factors; Aged; Bone Neoplasms; Breast Neoplasms; Bronchial Neoplasms; Cobalt Isotopes; Esophageal Neoplasms; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Radium; Skin Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms	1972
[Radiation pathology (demonstration)]. Strahlenschutz in Forschung und Praxis, 1973, Volume: 12 Topics: Alpha Particles; Animals; Bone Neoplasms; Female; Mice; Neoplasms, Radiation-Induced; Radioisotopes; Radium; Sarcoma, Experimental; Thorium	1973
Complications of radiation therapy: adult bone. Seminars in roentgenology, 1974, Volume: 9, Issue:1 Topics: Adult; Bone and Bones; Bone Diseases; Bone Neoplasms; Femur Head Necrosis; Femur Neck; Humans; Mandibular Diseases; Necrosis; Osteitis; Pelvic Bones; Radiation Dosage; Radiation Injuries; Radiography; Radiotherapy; Radium; Sarcoma	1974
Bone cancers induced by 224 Ra (Th X) in children and adults. Health physics, 1970, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Chondrosarcoma; Female; Fibrosarcoma; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Radiation-Induced; Osteosarcoma; Radiometry; Radium; Retrospective Studies; Sarcoma; Spondylitis, Ankylosing; Tuberculosis, Lymph Node; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary	1970
An epidemiologic approach to low-level radium 226 exposure. Public health reports (Washington, D.C. : 1896), 1966, Volume: 81, Issue:9 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Illinois; Infant; Infant, Newborn; Iowa; Male; Middle Aged; Neoplasms; Radium; Retrospective Studies; Water Pollution, Radioactive	1966
Radiation therapy of skin carcinoma. Journal of surgical oncology, 1971, Volume: 3, Issue:3 Topics: Aged; Bone Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Isotopes; Ear Neoplasms; Eye Neoplasms; Facial Neoplasms; Female; Hand; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Radiotherapy, High-Energy; Radium; Skin Neoplasms; Skull Neoplasms	1971
The radium standard for boneseekers--evaluation of the data on radium patients and dial painters. Health physics, 1967, Volume: 13, Issue:3 Topics: Accidents, Occupational; Bone Neoplasms; Environmental Exposure; Fractures, Spontaneous; Humans; Mastoid; Neoplasms, Radiation-Induced; Nose Neoplasms; Occupational Diseases; Osteomyelitis; Osteoporosis; Osteosarcoma; Paint; Radiation Injuries; Radiation Protection; Radiometry; Radium	1967
Radiation dose-time relations for induction of bone tumors in the dog and skin tumors in the rat. Radiation research, 1968, Volume: 34, Issue:3 Topics: Animals; Bone Neoplasms; Dogs; Female; Injections; Male; Neoplasms, Experimental; Osteosarcoma; Plutonium; Radium; Rats; Skin Neoplasms; Thorium; Time Factors	1968
Bone-seeking radionuclides. Science (New York, N.Y.), 1968, Aug-23, Volume: 161, Issue:3843 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Humans; Idaho; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiobiology; Radium; Skull Neoplasms; Strontium Isotopes	1968
Malignancy from radium. British journal of cancer, 1970, Volume: 24, Issue:2 Topics: Aged; Bone Marrow; Bone Neoplasms; Female; Humans; Leukemia, Radiation-Induced; Male; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Radiometry; Radiotherapy; Radium	1970
Speculated risk to bone and liver from 239 Pu. Health physics, 1970, Volume: 19, Issue:5 Topics: Adult; Animals; Body Burden; Bone Neoplasms; Child; Dogs; Female; Humans; Life Expectancy; Liver Neoplasms; Male; Maximum Allowable Concentration; Models, Biological; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Plutonium; Radiobiology; Radiometry; Radium; Species Specificity; Thorium	1970
Radium osteitis with osteogenic sarcoma: the chronology and natural history of a fatal case. Bulletin of the New York Academy of Medicine, 1971, Volume: 47, Issue:9 Topics: Adult; Bone Neoplasms; Female; Humans; Neoplasms, Radiation-Induced; Occupational Diseases; Osteitis; Osteosarcoma; Radiation Injuries; Radium	1971
The question of safe radiation thresholds for alpha emitting bone seekers in man. Health physics, 1971, Volume: 21, Issue:1 Topics: Alpha Particles; Bone and Bones; Bone Neoplasms; Environmental Exposure; Humans; Models, Biological; Neoplasms, Radiation-Induced; Osteosarcoma; Radiation Protection; Radiobiology; Radium; Time Factors	1971
Methods of assay of the relative toxicity of certain bone-seeking radionuclides. Radiation research, 1971, Volume: 48, Issue:2 Topics: Animals; Bone and Bones; Bone Neoplasms; Dogs; Injections, Intravenous; Mathematics; Methods; Models, Biological; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiation Dosage; Radiometry; Radium; Statistics as Topic; Strontium Isotopes; Thorium	1971
[Radiation carcinogenesis. Pathogenesis of radiation-induced neoplasms]. Strahlenschutz in Forschung und Praxis, 1970, Volume: 10 Topics: Bone Neoplasms; Chondroma; Chondrosarcoma; Fibroma; Humans; Neoplasms, Radiation-Induced; Osteoma, Osteoid; Osteosarcoma; Radium	1970
Radiation-induced sarcoma of bone. Cancer, 1971, Volume: 28, Issue:5 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Neoplasms, Radiation-Induced; Occupational Diseases; Osteosarcoma; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Radium; Retrospective Studies; Uterine Cervical Neoplasms	1971
[Late damages after 224Ra injections in men]. Monatsschrift fur Kinderheilkunde, 1970, Volume: 118, Issue:6 Topics: Adolescent; Adult; Age Factors; Bone Neoplasms; Child; Child, Preschool; Chondrosarcoma; Chromosomes; Congenital Abnormalities; Female; Fibroma; Fingers; Humans; Infant; Male; Osteosarcoma; Radiation Dosage; Radiation Effects; Radium; Sex Factors; Time Factors; Tuberculosis, Osteoarticular; Tuberculosis, Pulmonary	1970
Roentgenographic analysis of 226 Ra induced osteogenic sarcoma in mice. Neoplasma, 1971, Volume: 18, Issue:6 Topics: Adenocarcinoma; Animals; Bone Neoplasms; Mice; Neoplasms, Radiation-Induced; Osteosarcoma; Radiography; Radium; Sarcoma, Experimental	1971
Radium-induced malignant tumors in man. ANL-7461. ANL, 1968 Topics: Bone Neoplasms; Chicago; Female; Follow-Up Studies; Humans; Iatrogenic Disease; Leukemia; Male; Neoplasms, Radiation-Induced; Occupational Diseases; Radium	1968
Studies on short-lived internal -emitters in mice and rats. II. 227 Th. International journal of radiation biology and related studies in physics, chemistry, and medicine, 1971, Volume: 20, Issue:3 Topics: Alpha Particles; Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Feces; Half-Life; Mice; Neoplasms, Radiation-Induced; Radiation Dosage; Radiation Effects; Radium; Rats; Sarcoma; Thorium	1971
[Short-term effect of radiation on rectal and gastric mucosa: presentation of 2 cases]. L'union medicale du Canada, 1969, Volume: 98, Issue:8 Topics: Adenocarcinoma; Adult; Bone Neoplasms; Endometriosis; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Metastasis; Peptic Ulcer; Radiation Effects; Radium; Rectum; Time Factors; Uterine Neoplasms	1969
Application of 18F to image 226Ra-induced bone lesions. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1970, Volume: 11, Issue:5 Topics: Animals; Bone and Bones; Bone Diseases; Bone Neoplasms; Dogs; Fluorine; Radiography; Radioisotopes; Radionuclide Imaging; Radium; Regional Blood Flow	1970
The malignant tumour risk from radium body burdens. Health physics, 1970, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Body Burden; Bone Neoplasms; Brain Neoplasms; Environmental Health; Female; Follow-Up Studies; Humans; Leukemia, Radiation-Induced; Male; Maximum Allowable Concentration; Methods; Middle Aged; Models, Biological; Neoplasms, Radiation-Induced; Paranasal Sinus Neoplasms; Radiation Protection; Radium; Skull Neoplasms; Spinal Cord Neoplasms	1970
[Cervix carcinoma in multiple primary neoplasms]. Wiener medizinische Wochenschrift (1946), 1971, Mar-13, Volume: 121, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Bone Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Female; Gallbladder Neoplasms; Humans; Leiomyosarcoma; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Radium; Rectal Neoplasms; Stomach Neoplasms; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms	1971
The risk of bone cancer in man from internally deposited radium. The British journal of radiology, 1968, Volume: 41, Issue:485 Topics: Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Radium	1968
The risk of bone cancer in man from internally deposited radium. The British journal of radiology, 1968, Volume: 41, Issue:485 Topics: Bone Neoplasms; Humans; Neoplasms, Radiation-Induced; Radium	1968
Mortality from primary tumours of bone in England and Wales. British journal of preventive & social medicine, 1969, Volume: 23, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Bone Neoplasms; Child; Child, Preschool; Death Certificates; England; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasms, Connective Tissue; Osteitis Deformans; Radium; Sex Factors; Wales; Water Pollution, Radioactive	1969
The relative toxicities of radium 226, plutonium 239 and strontium 90 for bone tumour induction. The British journal of radiology, 1966, Volume: 39, Issue:466 Topics: Animals; Bone Neoplasms; Mice; Neoplasms, Experimental; Plutonium; Radiation Injuries, Experimental; Radium; Strontium	1966
DIAGNOSIS OF BONE METASTASIS BY PHOTOSCANNING WITH STRONTIUM 85. JAMA, 1964, Apr-06, Volume: 188 Topics: Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Humans; Male; Neoplasm Metastasis; Neoplasms; Prostatic Neoplasms; Radio; Radioisotopes; Radionuclide Imaging; Strontium; Strontium Isotopes	1964